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I NTRODUCT I ON 
Herpes S impl e x V i rus and C e rv i ca l Ca rc inoma 
W i t h in t h e  past d e cade , t h e r e  has been increas ing evi ­
d en c e  wh i c h  sug g es ts that herpes s imp l e x  v i rus type two 
(HSV - 2 )  is assoc iat e d  w i t h  c e r v i ca l  ca rc inoma .  Be cause 
canc e r  of  t h e  c e rv ix ranks as t h e  s e c ond most common mal i g ­
nant d is ease o f  women , w i t h  3 S  t ho usand new cases and 
1 0 , 0 0 0  d ea t hs p e r  y ear , fur t h e r  inves t i gat i on is war rant e d  
to  d e t e rm i n e  i f  t h e r e  is a causal r e lat ions h i p  ( Go l db e r g , 
1976). Current l y , most o f  t h e  e v i d enc e wh i c h  c o r r e la t es 
HSV - Z  w i t h  can c e r  o f  t h e  c e r v i x  has b e en , for  t h e  most 
part , ind i r e c t : ( i )  t h e r e  is an i n c r ease d  inc i d enc e o f  
c e rv i ca l  anap las ia i n  women w i t h  cyto l o g i ca l l y  d e t e c tab l e  
g e n i ta l  he rpes i n fe c t ion , ( i i )  many pat i e nts w i t h  c e rv i ca l 
carc inoma hav e a h i g h  t i t e r  o f  spec i f i c  neutra l i z ing ant i ­
body to  HSV - Z ,  ( i i i )  HSV - Z has b e en iso l a t e d  from a c e l l  
cul t ur e  d e r i v e d  from o n e  car c i noma i n  s i tu (Au r e l ian , 
1976), ( iv )  HSV - Z membrane ant i g ens we r e  d e t e c t e d  in a 
sma l l  p e rc entage o f  c e l ls from a c u l t u r e  not  y i e l d in g  in ­
fec t i ous v i rus .  I n  add i t i on to  t h e  c o r r e lat ive s t ud i es ,  
the t rans fo rming  capac i t y  o f  HSV - 2 for  human embryon i c  
c e l ls has b e en c1ea r l y  d emons t ra t e d  in v i t r o , a n d  ( v i )  
hams t e r  c e l ls t rans fo rmed i n  v i t r o b y  t h e  v i rus have onco­
gen i c  p o t en t ial when inj e c t e d  i n t o  hams t e rs ( Rapp an d Re e d , 
1976). Lac k  o f  mo r e  d i r e c t  e v i d enc e in r e lat ion to  human 
carc inoma ,  howev e r , such as t h e  inab i l i t y to demons t rate  
2 
hyb r i d i za t i o n  o f  HSV - 2 nuc l e ic ac i d  w i t h  tha t  in the c e r ­
v i ca l carc inoma c e l l  has l e ft t he issue o f  HSV - 2  and c e r ­
v i ca l  car c inoma can c e r  t h e  sub j e c t  o f  cons i d e rab l e  cont ro­
v e rsy ( z u rHausen , 1 9 7 6 ) . 
Lat ent I n fe c t i o n  w i t h  He rp es S i mp l e x  V i rus 
I n  add i t i on t o  t h e  poss i b l e  ro l e  o f  HSV - 2 in in i t iat ­
ing c e r v i ca l  car c inoma ,  t h e  herp es s imp l ex v i ruses o f  b o t h  
t y p e  1 a n d  2 a r e  rat h e r  ub i qu i t ous v i ruses wh i c h  a r e  common 
pat ho g ens o f  man . Stat ist i ca l  eva l uat i on has ind i ca t e d  
that 7 0 -8 0  p e rc en t  o f  a l l  i nd i v i dua ls g r ea t e r  than 15 y ea rs 
o f  age  have b e e n  i n fe c t e d  w i t h  e i t h e r  HSV - l  o r  HSV- 2 . 
Mo r e o ve r , at  l east one - t h i rd o f  ind i v i duals w i t h  ant i b o dy 
to  HSV deve l o p  c l in ical l y  appa r en t  r eac t i vat ion (Thong et  
a l . ,  1 9 75 ) . H SV - 2  is usua l l y  assoc ia t e d  w i th l es i ons in 
t h e  gen i ta l  a r ea and is s e c ond only t o  gono r rh ea as the 
most p r e va l ent f o rm of vene real d isease ( Kl e in , 1 9 7 6 ) . In  
compa r ison t o  HSV- l ,  HSV - 2 app ears t o  b e  mo r e  neuro t r o p i c  
in exp e r i mental a n i ma l  sys t ems ( Da v is e t  al . ,  1 9 7 3 ) . 
Neonatal h e rp e t i c i n f e c t ions a r e  o ft e n  t h e  r esu l t  o f  
mo t h e rs harb o r i n g  g e n i ta l  HSV- 2  i n fe c t ion and are usua l l y  
severe  o r  even fatal for  t h e  newborn . 
The propens i t y  for  r e c urrent i n f e c t i o ns is also a 
prop e r t y  o f  t h e  h e r p es s i mp l ex v i ruses . La t en t  HSV - l  and 
HSV - 2  have b e e n  iso l a t e d  from senso r y  and aut onom i c  gan g l ia 
i n  s i t uat i o ns wh i c h  may man i fest no c l i n i cal symp toms 
( Bar i n g e r , 1 9 7 4 ) . Recurrent  i n f e c t i ons o f  b o t h  HSV - l  and 
HSV - 2  have b e en shown t o  occur  no t as a consequence o f  
3 
re - i n fe c t ion but rat h er t h e  ma int enanc e  o f  t h e  v irus in a 
non i n fe c t i ou s  s ta t e  ( St evens and Cook , 1 9 7 1 ) . The me cha ­
n i sms b y  wh i c h  t h e  v iru s i s  rea c t i va t e d  t o  cau s e  in fec t i on 
and t h e  ab i l i t y  o f  t h e  v irus t o  r e s i d e  i n  the ho s t  in a 
latent  s ta t e  are n o t  we l l  under s t o o d . 
A numb er o f  inve s t i ga t ors  have d emon s tra t e d  t h e  ex i s ­
t en c e  o f  v irus i n  t h e  ho s t  b e tween i n t erva l s  o f  overt in ­
fec t i on in t h e  s en s ory gan g l ia innervat i n g  the ar ea o f  i n ­
fe c t ion ( S t ev e n s  and Co o k ,  1 9 7 6; Bar in g er , 1 9 75 ) . Bar i n g er 
et  a l . ( 1 9 75 )  repor t e d  r e c overy o f  HSV - 2 v irus from human 
sacra l  gan g l ia from pat i en t s  who were known to have had a 
h i s t ory o f  r e c urre n t  g en i ta l  HSV - 2 infe c t i on .  An i ma l  
s y s t ems have a l s o  b e en e s tab l i s h e d  wh i c h  demons tra t e  t h e  
pre s en c e  o f  v irus i n  gan g l ia fo l l owing  var i ous  rout e s  o f  
infec t i on ( S t evens  a n d  C o o k , 1 9 7 6; H i l l , 1 9 75) . 
I n  s p i t e  o f  a l l  t he ava i lab l e  e v i denc e conc ern ing the 
e x i s t en c e  of latent v iru s , t here ar e c urrent l y  no s u ff i ­
c i ent mo de l s  for s t udying  t h e  mechan i sm s  o f  ma int enan c e  and 
r eac t i vat ion o f  v irus  under experimenta l l y  contro l l e d  
cond i t i o n s . Th er e  ar e s e veral hypo t h e s e s  wh i c h  a t t empt to  
exp l a i n  t h e  mechan i sm ( s )  of  latency , ran g i n g  from t h e  
b i o c he m i ca l  s ta t e  o f  t h e  v irus t o  the ro l e  o f  immun o l o g i ca l  
mec han i s ms wh i c h  may prevent t he v irus  from be i n g  expre s s e d  
in a n  i n fe c t i o u s  s ta t e  ( St evens a n d  Co o k ,  1 9 7 4 ) . Th e 
lat t er hyp o t he s e s  i nvo l v e  t h e  ro l e  o f  s p e c i f i c  an t ibody and 
c e l l - me d iat e d  re s p o n s e s  as mechan i sm s  by wh i c h  the v irus 
is ma i nta i n e d  in a q u i e s c e n t  s ta t e  in the ho s t  ( S t evens and 
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Cook , 1974; Lehner e t  a l . ,  1975). Recurrenc e s  are exp la ined 
by d e crea s e d  l e ve l s  of  I g G or p o s s i b l e de fec t s  in the 
e xpre s s i o n  o f  humoral or c e l l - me d ia t e d  immun i t y . The 
ab i l i t y  of t he v irus to b e c ome r ea c t i va t e d  by such fac t ors 
a s  trauma , s un l i g h t , or s tre s s  may b e  e xp lained  by the fac t  
t h e s e  fac tors may c o n tr i b u t e  t o  t h e  a l t erat i on o f  neurons 
such t hat sp e c i f i c  ant ibody can no l on g er bind to the 
membrane and t he v irus is  depre s s e d  and can pr o c e e d  into  
the rep l i cat ive c yc l e s  ( S t evens and C o o k , 1974). 
I mmuno l ogy o f  Herpe s  S i mpl e x  V irus I n fe c t ion 
With t he i ncrea s i n g  accumu lat ion of  data conc ern i n g  
t h e  immune r e s p o n s e  t o  herp e s  s imp l e x v irus infec t i on ,  i t  
i s  now apparent t ha t  h o s t  re s i s tanc e to  t h i s  v irus embra c e s  
a comp l e x  n e t work o f  immuno l o g i ca l  int erac t i ons . The s e  
inc l ude s p e c i f i c  humora l and c e l l - me d ia t e d  immuno l o g i cal 
parame t ers  a s  we l l  a s  nonsp e c i f i c  fac t ors . The relat i ve 
c ontr ibut i o n  o f  eac h o f  t h e s e  a sp e c t s  rema in s  t o  b e  e l uc i ­
dat e d .  
Ro l e  o f  Thymu s - D ependent C e l l s  
The i n i t ia l  s u gg e s t ion t ha t  T - c e l l s  were important 
in re s i s tanc e  to herp e t i c  i n f e c t i on , s t ems , in part , from 
o b s ervat i o n s  t hat. immuno suppr e s s e d  or T - c e l l  de f i c i ent pa ­
t i ent s ar e pre d i sp o s e d  t o  a h i gher inc idence  and increa s e d  
s ever i ty o f  herp e t i c inf ec t i on s  (Mont gomer i e  e t  a l . ,  1969). 
Pat i en t s  on t h erapeut i c  immuno s uppre s s ion , such as  tran s ­
p lant rec ip i ent s , have b e e n  repor t e d  t o  have a h i gher 
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inc i de n c e  o f  d i s s em i n a t e d  h e r p e t i c  d i s e a s e  than do immuno­
l o g i c a l l y  no rma l i n d i v i dua l s  ( Rand e t  a l . ,  1976; Ko r s a g e r  
e t  a l . ,  1975). F u r t h e rmo r e , in v i t r o , Rand a n d  c o - wo r k e r s  
(1976) repo r t e d  r e l a t i v e l y  g o o d  c o rr e l a t i o n  b e tween in ­
c r e a s e d  r i s k  t o  h e rp e t i c  i n fe c t ion in c a r d i ac t r an s p l ant 
pat i e n t s  and a d e p r e s s e d  s t a t e  of in v i t ro l ympho c y t e  
t r an s forma t ion t o  m i t o g e n s  o f  s p e c i f i c ant i g ens . The 
i n f e c t ion may b e  e x o g enou s , a l though i t  ha s b e en p r e s ume d , 
in some i n s t anc e s  t o  b e  a t t r i bu t e d  t o  b e i n g  a r e s u l t  o f  
r e ac t i va t i o n  o f  a l a t e n t  infec t io n  ( Ko r s a g e r  et  a l . ,  1975). 
Other  immuno d e f i c i en t  s t a t e s  s uc h  a s  t h e  Wi s ko t t - A l d r i c h  
syndrome a n d  c e r t a in l ympho r e t i c u l a r  d i s o r d e r s  a l s o g ive  
r i s e  to  h i gh e r  inc iden c e s  and i n  many c a s e s  mo r e  s e v e r e  
h e rp e t i c  d i s e a s e s  o f  b o t h  HSV - l a n d  HSV - 2 t h a n  in p a t i e n t s  
w i t h  adequate  i mmun e r e s p on s e s  ( S t. Geme , 1976; Ran d , 
1976). 
I nve s t i g a t i o n s  u s i n g  e x p e r iment a l  an imal mo d e l s  have 
c o n f i rme d t ha t  c e l l - me d i a t e d  immun i ty is an impo r t an t  
mec han i sm i n  r e s i s t an c e  t o  i n f e c t i on o f  H S V  t y p e s  1 a n d  2 
( Lo dme l l  e t  a l . ,  1973; Enn i s  e t  a l. ,  1974). Thyme c tomi z e d , 
ant i - t hymo c y t e  t re a t e d  o r  c y c l opho spham i d e  t r e a t e d  m i c e  
showed a marked i n c r e a s e  i n  s u s c e p t i b i l i t y  to  t h e  l e t h a l  
cons equenc e s  o f  HSV i n fe c t ion (Mo r i  e t  a l . ,  1967; Z i sman e t  
a l . ,  1969; Oak e s , 1975). Th i s  wa s a l s o  man i fe s t e d  i n  
augme n t e d  l eve l s  o f  v i ru s  r e c o v e r e d  from the bra in and 
l iv e r  ( Ra g e r - Z i sman and Al l i s on , 1976). To l end fur t h e r  
c re d ence t o  t h e  i mpo r t an c e  o f  T - c e l l s , p a s s ive l y  t r ans f e r r e d  
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immune spleen cells restored normal resistance to infected, 
immunosuppressed animals. The protective capacity of these 
spleen cells was abrogated by pretreatment with anti-theta 
serum and complement to remove T-cells (Ennis and Wells, 
1974). 
The precise mechanism (s) by which T-cells are able to 
mediate this antiviral activity are unclear. Information 
obtained from in vitro studies have suggested several 
possibilities. 
Production of interferon may well be involved in the 
antiviral activity. Lodmell and Notkins (1974) demonstrated 
that BeG immune lymphocytes stimulated in vitro with puri­
fied protein derivitive (PPD) mediated their activity 
against HSV-l in a nonspecific manner through the produc­
tion of interferon. Furthermore, Fujibayashi et al. (1975) 
demonstrated the production of interferon by HSV-immune 
lymphocytes cultured in vitro in the presence of HSV 
antigen-antibody complexes. These cells also showed an 
increased proliferative response. Unlike sensitized leuko­
cytes, normal leukocytes did not produce interferon in 
vitro but did also exert an antiviral effect (Lodmell and 
Notkins, 1974). This effect, however, was only observable 
when the ratio of" leukocytes to infected target cells was 
very high; thus, it was assumed to be a generalized non­
specific cytotoxic effect (Lodmell and Notkins, 1974). 
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A second antiviral mechanism which may be operative in 
I-ceIl-mediated resistance may be through a specific cyto­
toxic response exerted by immune murine I-cells against 
virus induced antigens expressed on the surface of target 
cells. Ihis reaction has been demonstrated in several 
viral systems in vitro, and appears, in some cases, to 
require certain identities in the histocompatibility region 
between target and effector I-cells (Blanden et al., 1976; 
Zinkernagel, 1975). 
Ihere have been relatively few definitive reports con­
cerning the cytotoxicity of immune I-cells from HSV-infected 
animals or humans. Leukocyte-mediated cytolysis has been 
reported in the human against HSV-infected cells but rigo­
rous characterization of the cells and the mechanism (s) in­
volved has not been performed (Russell and Kaiser, 1976). 
Pfizenmaier et al. (1977) reported that HSV-immune cyto­
toxic I-cells could be generated by removing I-cells from 
lymph nodes draining a local site infected with HSV-l, 
followed by a seventy-two hour incubation in vitro. Con­
ventional direct I-cell cytotoxicity assays against HSV­
infected cells have been comparatively less successful thus 
far. 
In spite of "the lack of data available concerning HSV 
cytotoxicity, there have been several reports of direct I­
cell cytotoxicity with herpes viruses other than herpes 
simplex. Rouse et al. (1977) demonstrated antiviral cyto­
toxicity with immune peripheral blood lymphocytes against 
8 
infectious bovine rhinotracheitis (IBR) virus or feline 
rhinotracheitis virus (Wardley et al., 1976). In contrast 
to the findings of Zinkernagel and Blanden, in studies with 
the bovine system, there was no apparent histocompatibility 
requirement between effector and target cells. The immune 
T-cells killed autologous as well as homologous infected 
cells (Rouse et al. , 1977). The disparity between require­
ments or lack of requirements for genetic restriction may 
well be due to the nature of the histocompatibility systems 
among the different species. 
Other mechanisms of antiviral activity attributed to 
the T-cell include production of various soluble factors, 
in addition to interferon. Peripheral blood lymphocytes 
from humans which were seropositive for HSV produced lympho­
toxin as well as lymphocyte-derived chemotactic factor when 
exposed to HSV antigen in vitro (Rosenberg et al., 1974). 
Other factors such as migration inhibitory factors have 
also been reported following exposure of immune lymphocytes 
to HSV antigen (Snyderman, 1972). The significance of 
these soluble factors during viral infection in vivo has 
not been defined; thus it would be somewhat premature to 
establish a definitive role. 
Humoral Immunity to Herpes Simplex Infection 
The role of antibody in protection from primary and 
recurrent herpetic infection is somewhat paradoxical. The 
contradictions stem from the observations that persons sub­
ject to recurrent infections generally have a consistently 
high titer of circulating antibody to HSV (Rand, 1976). 
The obvious question, therefore, is whether antibody to HSV 
plays a protective role against recurrent infection, as 
suggested by Stevens and Cook concerning the maintenance of 
latency (Stevens and Cook, 1975). 
Antibody to HSV-l and HSV-2 have been demonstrated to 
be of the IgM and IgG classes, generally speaking. There 
is a considerably high degree of cross-reactivity of HSV-l 
and HSV-2 antibody as a result of the antigenic similari­
ties shared by the two types. Consequently, infection by 
one type may give rise to antibody capable of reacting with 
both types 1 and 2 (Plummer et al. , 1968). Although the 
precise mechanisms of virus-antibody interactions are not 
well understood, it is presumed that antibody may exert an 
antiviral effect in several ways. Neutralizing antibody 
may exert its effect by direct inactivation of extracellu­
lar virus, thus limiting the spread of virus to surrounding 
cells (Ennis, 1973). There may be antibody present capable 
of recognizing viral antigens on the surfaces of infected 
cells, and in the presence of complement, causing destruc­
tion of these cells (Brier et al. , 197 1). Whether these 
responses are of major importance in protection against 
recurrent infection is unclear. Various results, however, 
indicate that passive transfer of immune serum affords some 
protection to animals when given prior to primary challenge 
with virus (Breinig et al., 1978; Zisman and Allison, 
1976). A shortcoming of antibody-mediated protection is 
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the fact that while HSV may spread extracellularly, it may 
also spread contiguously to adjoining cells through intra­
cellular bridges, limiting the effect of antibody (Pavan 
and Ennis, 1977). This may at least, in part, account for 
the fact that patients with chronic T-cell suppression may 
have severe herpetic lesions, in spite of the presence of 
high levels of circulating HSV antibody (Lodmell et al., 
1973). 
Another role for specific neutralizing antibody to HSV 
has been suggested recently by Day et al. (1976). They 
reported that specific antibody characteristic of the 19E 
class could be found in rabbits sensitized with HSV. This 
antibody, like other classical 19E antibodies, may function 
to mobilize or activate cells associated with classic 
inflammatory response such as mast cells and basophils. 
Thus, while antibody can prevent primary HSV infec­
tion, the protective role of antibody in recovery from 
primary infection, or in prevention of or recovery from 
recurrent herpetic disease, remains somewhat elusive. The 
accumulating evidence suggests, however, that while anti­
body may be protective, it is not necessarily essential for 
recovery from infection (Rand et al. , 1976). A more compre­
hensive understanding of the mechanisms of latency and 
reactivation may help to define the relative importance of 
this aspect of the immune response. 
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Synergistic Action of Humoral and Cell-Mediated Responses 
There is a preponderance of evidence suggesting that 
cooperation of cell-mediated and humoral parameters may 
well be an effective antiviral host defense mechanism. 
Antibody-dependent cell-mediated cytotoxicity (ADCC) has 
been demonstrated in vitro in several tumor as well as a 
variety of virus systems including several in the herpes 
virus group (Ralph, 1975; Moller-Larsen, 1977). The re­
sponse involves the cooperation of antibody and effector 
cells in generating a specific cytotoxic resopnse against 
the appropriate target cell. 
In the system of Shore et al. (1977) using human 
peripheral blood, characterization of the effector cell 
revealed an Fc-receptor bearing cell lacking surface Ig, 
lacking the ability to form E-rosettes, and lacking the 
ability to phagocytose carbonyl iron. Thus, the activity 
was ascribed to a killer cell (K-cell) (Perlmann et al., 
1975; Shore et al., 1976; Shimizu et al., 1977; Melewicz 
et al. , 1977). Characterization of this cell in the HSV 
system has been confirmed by others (Heron, 1977). There 
appears to be no requirement for previous sensitization for 
this cell to mediate a cytotoxic response in the presence 
of the appropriate' antibody. There is a requirement for 
the presence of relatively low levels of specific antibody 
of the IgG class, which appears to attach directly to the 
target cell rather than directly activating the mononuclear 
K-cell (Shore et al., 1976). This antibody is capable of 
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crossing the placental barrier and cooperating with cord 
blood mononuclear cells in mediating ADCC. Shore et al. 
(1977) have proposed that this may be one way in which the 
neonate may be protected from herpetic infection in utero. 
An interesting feature of ADCC in the HSV system is 
the rapidity with which this effector mechanism can recog­
nize and subsequently destroy HSV-infected target cells in 
vitro. Reports have demonstrated that viral antigens 
expressed on the surface of infected target cells are re­
cognized by ADCC effector cells as early as two hours after 
infection, and that significant damage to these targets can 
be produced within three hours after infection. By de­
stroying the infected cells early during the course of 
infection, the release of mature viral progeny was markedly 
reduced, thus obviating contiguous as well as extracellular 
viral spread (Shore et al., 1977a). The degree of ADCC was 
dependent upon the degree of infectivity of the target 
cells; the higher the multiplicity of infection, the 
greater the cytotoxic response (Shore et al. , 1976). Thus, 
it has been suggested that the phenomena of antibody­
dependent cell-mediated cytotoxicity may be important 
mechanisms early during the course of infection and prior 
to the onset of specific cellular immune responses. 
Role of the Macrophage in Resistance to HSV Infection 
Johnson (1964) was of the first to report an age­
related factor in resistance to extraneural HSV infection. 
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Resistance to intraperitoneal or intranasal HSV infection 
seemed to increase with increasing age. Investigation into 
the level at which the spread of extraneural HSV was inhi­
bited revealed a correlation between acquisition of resis­
tance and the maturation of macrophages. Infection with 
HSV of adult and suckling mouse macrophages in vitro demon­
strated that the ability of virus to spread and infect 
surrounding cells was considerably greater in the cultures 
of infected immature macrophages than in macrophages from 
adults. The inability of age to alter the outcome of 
intracerebral infection with HSV was explained by the 
phenomenum of the blood brain barrier, which further sup­
ported the role of the macrophages in resistance to peri­
pheral HSV infection. 
Subsequent investigation by Stevens and Cook (1971) 
and Hirsch et al. (1970) described virus cell interactions 
in infected mouse macrophages. Confirming and extending 
the work of Johnson (1964), Hirsch and co-workers (1970) 
reported that restriction of HSV by mature macrophages was 
a result of improper viral assembly in the cell. Despite 
the fact that the entire spectrum of viral components in 
the macrophage was apparently produced, the number of 
infectious virions· decreased as a result of the inability 
to assemble the virions, a property unique to the adult 
macrophage. The exact mechanism of intrinsic restriction 
of the macrophage is still not clear, however, and remains 
a subject of considerable interest. 
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In further support of the role of the macrophage in 
resistance to viral infection, Starr et al. (1976) demon­
strated that an agent capable of activating macrophages 
could confer protection against HSV infection in the neo­
natal host. Administration of BCG six days prior to an 
intraperitoneal challenge of HSV-2 significantly protected 
neonatal mice from lethality as compared to normal controls. 
Several mechanisms have been proposed. The possibility 
exists that BCG activates macrophages (or matures the 
"immature" macrophages of the neonate) which subsequently 
limit viral spread in vivo. Lodmell et al. (1973) have 
reported the ability of immunologically activated macro­
phages to decrease HSV-2 spread in vitro, which provides 
correlative evidence to support this hypothesis. Whether 
or not activating agents act directly on the macrophage or 
stimulate the production of substances (lymphokines) which 
subsequently activate macrophages in vivo has not been 
resolved. 
Attempts have also been made to determine the role of 
macrophage resistance to HSV infections by eliminating or 
impairing macrophage function in vivo. Zisman et al. 
(1969) demonstrated that intraperitoneal pretreatment of 
young adult mice with silica significantly decreased resis­
tance to an intraperitoneal challenge with HSV-l. Enhance­
ment of mortality was also noted in mice pretreated with 
anti-macrophage serum, although it should be noted that 
the antiserum preparation was relatively crude and partially 
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toxic to cell populations other than macrophages. Pro­
longation of skin allografts have been achieved by pre­
treatment with silica (Pearsall et al., 1968). Clearance 
of colloidal carbon from the reticuloendothelial system was 
depressed following silica treatment as well as the ability 
to transfer tumor immunity by immune macrophages (Pearsall 
et al., 1968). Treatment of macrophages in vitro by silica 
has been shown to inhibit the phagocytic ability of macro­
phages to a marked degree (Miller and Zarkower, 1974). 
Other compounds such as dextran sulfate and trypan 
blue have also been shown to impair macrophage function. 
While Allison (1966) has proposed that the mechanism of 
action of silica ultimately involves autolysis of the 
macrophage, it has been suggested that trypan blue and 
dextran sulfate do not destroy the cell, but rather inhibit 
lysosomal enzyme activity, thus impairing phagocytic func­
tion (Hibbs, 1975; Hahn and Bierther, 1974). In work with 
the effect of dextran sulfate on resistance to Listeria 
infection, Hahn (1974) demonstrated a marked increase in 
the number of organisms recovered from the liver and spleen 
of mice infected systemically and treated with dextran 
sulfate, and subsequently enhanced mortality. Electron 
microscopic examination of macrophages from mice treated in 
vivo with the compound showed marked morphological changes 
(Hahn and Bierther, 1974). Using trypan blue as an inhi­
bitor of macrophage function, Hibbs demonstrated that the 
antitumor activity of macrophages could be blocked by 
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pretreatment of mice with this compound (Hibbs, 1975). The 
effects of these macrophage inhibitors on viral infections 
have not been determined. 
Therapy Against Herpes Simplex Infection 
There are currently no satisfactory therapeutic moda­
lities available in the treatment of herpetic disease 
(Alford and Whitley, 1976). Chemotherapeutic agents such 
as cytosine arabinoside, iododeoxyuridine and others have 
limitations with respect to clinical value because of their 
relatively high levels of toxicity (Alford and Whitley, 
1976). Most of the drugs currently administered in the 
treatment of herpetic disease are derivatives of purine and 
pyrimidine bases which act nonspecifically in that the site 
of action involves cellular DNA as well as viral DNA 
(Alford and Whitley, 1976). Thus, these drugs, in thera­
peutic doses, may markedly suppress actively dividing cells 
such as those of the myeloid series. Consequently, this 
mode of therapy may bear a two-fold effect - they may be 
beneficial with respect to antiviral activity, but at the 
same time may antagonize the development of immune mecha­
nisms which may be important in the recovery from herpetic 
infection. Another form of therapy using photoinactivation 
of the virus by treatment of an active lesion with dye and 
light has been shown to be useful in the management of 
active lesions. However, this is not without limitations 
due to the fact that the combination of heterocyclic dye 
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and ultraviolet light may be mutagenic (Cusumano et al., 
1975). 
Another aspect to be considered in the development of 
an efficacious agent for the treatment of herpes simplex is 
that unlike most other viral diseases, the virus may estab­
lish latency in the host. While the mechanisms of latency 
have not yet been fully elucidated, it is unlikely that the 
chemotherapeutic agents currently available would ablate a 
latent infection without producing significant damage to 
the host. 
An alternative approach to chemotherapy which has re­
ceived increasingly widespread attention involves utiliza­
tion of the immune system. This may be broadly classified 
into two methods of approach - development of a protective 
vaccine against herpes simplex which offers minimal risk to 
the host and modulation of the host response. As with the 
development of any vaccines suitable for human use, several 
parameters must be considered extensively. There are addi­
tional factors to consider in the preparation of a herpes 
virus vaccine, attributable to the latent and oncogenic 
potential of the virus. These two problems, in addition to 
the risk of introducing a potentially lethal infection into 
the host through viccination, have almost completely eli­
minated the possibility of using a live virus vaccine, 
although a live virus vaccine generally affords a longer 
lasting immunity (Biggs, 1977; Hilleman, 1976). 
Potentially hazardous consequences may also be associated 
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with the use of a killed herpes simplex vaccine. Aside 
from the relatively poor preliminary results concerning the 
protective capacity of an inactivated preparation of the 
virus against primary and recurrent herpetic disease is the 
fact that some of the conventional methods of inactivation 
such as ultraviolet light exposure may enhance the onco­
genic potential of the virus (Rapp and Reed, 1976). 
Thus, it appears that the most practical herpes sim­
plex vaccine would consist of a nucleic acid free subunit (s) 
which would be protective against the establishment of 
primary or recurrent disease with a minimal risk to the 
host. This approach, however, is not totally without 
problems, due to the relatively low efficacy of many sub­
unit vaccines in addition to some problems intrinsic to the 
herpes viruses. Such problems include the difficulties 
associated with the purification of subvirion components. 
Components of the virion of HSV tend to be quite unstable 
and easily damaged during conventional purification methods 
and, thus, antigenic components may be damaged or altered. 
Development of appropriate purification techniques may ac­
celerate the advent of a subunit herpes vaccine (Powell et 
al., 1975). 
A second immunologic approach to dealing with herpetic 
disease is through immunomodulation, which involves the 
manipulation of host defense mechanisms through the admin­
istration of synthetic or naturally occurring agents 
(immunomodulators). Immunotherapy has, in the treatment of 
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certain malignant diseases, become a realistic therapeutic 
modality (Bluming et al. , 1972). The question, however, as 
to whether these agents may have therapeutic value in the 
treatment of certain viral diseases has not been suffi­
ciently answered. The mechanisms by which immunomodulators 
act has also not been completely delineated, and probably 
differs with the particular tumor or microbial system. 
However, nonspecific activation of macrophages has been 
demonstrated to be involved in many of the effects of 
certain immunomodulators such as pyran and f. parvum, es­
pecially antitumor activity (Kaplan et al. , 1977; Morahan 
et al. , 1977). Some evidence is also available concerning 
the role of immunomodulator activated macrophages in anti­
viral activity (Breinig et al. , 1978). 
Morahan et al. ( 1977) demonstrated the antiviral 
activity of pyran or Corynebacterium parvum activated peri­
toneal exudate cells in vitro. When mouse embryo fibro­
blasts were infected with vaccinia virus and incubated in 
the presence of activated peritoneal exudate cells, there 
was a significant inhibition in the number of plaque­
forming units as compared to those cultures containing 
nQrmal (resident) peritoneal cells or no peritoneal cells. 
Peritoneal cells stimulated with glycogen showed limited 
antiviral activity and, unlike pyran or f. parvum activated 
peritoneal cells, did not possess cytotoxic activity against 
osteogenic sarcoma cells. 
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The macrophage activity was demonstrated to be nonspe­
cific because activity was shown against three different 
viruses. In addition to pyran and f. parvum activated 
peritoneal cells, peritoneal cells taken from mice infected 
with vaccinia virus also possessed nonspecific antiviral. 
Rodda and White (1976) have also demonstrated nonspecific 
antiviral activity of peritoneal cells taken from mice 
previously infected with Semliki Forest virus and origi­
nally attributed this to macrophages. However, a recent 
paper (MacFarland et al. , 1977) reported that the cells 
were probably really natural killer cells. 
The mechanism (s) by which these activated peritoneal 
cells are able to prevent the growth of virus in suscep­
tible cells is not well understood. Other questions yet to 
be resolved include a possible requirement for histocom­
patibility or species identity between effector and target 
cells, whether or not the effector cells recognize virus­
infected cells or directly inactivate the virus, and 
whether the effector cells inhibit infection at extra­
cellular or intracellular levels. It is tempting to sug­
gest that the activated macrophage is the primary effector 
cell responsible for the antiviral activity in these peri­
toneal cell populations. However, the heterogeneity of the 
population is such that separation of these cells into sub­
populations is needed to identify definitively the effector 
cell (s). 
2 1  
The Research Plan 
The objectives of the present research can be broadly 
classified into two categories: (1) the role of the ad­
herent peritoneal cell (macrophage?) in nonspecific resis­
tance to HSV-2 infection in vivo and in vitro, and (2) 
demonstration of one aspect of specific cell-mediated 
immunity to HSV-2 infection in vivo. Although the mono­
nuclear phagocyte system and cellular immune system are 
recognized as having distinct functions in the network of 
immune responses, they are not entirely separate entities. 
It has been well established that the macrophage is ne­
cessary in many T-cell-mediated functions, both during the 
inductive phase of cellular immunity and in the effector 
stages (Yano et al. , 1977; Erb et al., 1975). The aspect 
of cellular immunity studied in this research has involved 
the cooperative effect between macrophages and T-cells in 
the delayed-type hypersensitivity response. The role of 
the macrophage was also investigated alone, in the absence 
of T-cells. 
The macrophage, because of its ability to evoke a 
state of nonspecific resistance, seems to be a likely 
candidate for being an important effector cell early during 
the course of initial infection, prior to the onset of 
specific humoral and cellular functions. Therefore, one 
aspect of this research has dealt with the role of macro­
phages early during the course of HSV-2 infection, and the 
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use of an in vitro model for investigating the antiviral 
activity of peritoneal exudate cells. The second aspect of 
the research dealt with the establishment of a system to 
investigate the appearance of a specific delayed-type 
hypersensitivity response in vivo following infection. 
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MATERIALS AND METHODS 
Mice 
Mice used for all investigations were of the BALB/c 
strain. This strain has been demonstrated to have a com-
paratively high susceptibility to HSV (Lopez, 1975) and has 
been used in previous and ongoing research in our labora­
tory (McCord and Morahan, 1975). The mice ranged from five 
to eight weeks of age except in those experiments requiring 
suckling mice, which ranged in age from one to seven days. 
The mice were maintained on Laboratory Chow and water ad 
libitum. Infected mice were housed in a room separated 
from normal uninfected mice. 
Virus 
The initial virus was obtained from Dr. Robert W. 
Tankersly. The virus was confirmed to be type 2 by the 
indirect hemagglutinin assay performed through the courtesy 
of Dr. John Stewart, Center for Disease Control, Atlanta, 
Georgia (McCord and Morahan, 1975). 
A virus pool was prepared by infection of a subcon­
fluent (75% confluent) monolayer of HEP-2 cells (approxi­
mately 107 cells/125 cm2 bottle) with approximately 5 x 105 
plaque-forming units (PFU) of the initial isolate. The 
virus was adsorbed for one hour at 360C followed by the 
addition of EMEM (Eagle's minimal essential medium con­
taining Earle's balanced salt solution - antibiotics, L­
glutamine) and 10% heat inactivated fetal calf serum. The 
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cells were incubated at 360C until cytopathic effect (CPE) 
was noted to be in 75% of the cells. 
Virus was harvested by freeze-thawing the infected 
cultures at -700C followed by low speed centrifugation to 
remove cellular debris. The supernatant fluid was removed, 
dispensed into 1 dram vials and stored at -700C. The titer 
was 5 x 10 PFU/ml when titered on HEP-2 cells. This pool 
was designated lA since it represented the first passage of 
the original isolate. For all experiments in vitro and in 
vivo, pools 4B and 5B of HSV-2 were used. They represented 
the fourth and fifth pools, respectively, of virus made 
from pool lAo 
Media 
All cell cultures were maintained in Eagle's Minimal 
Essential medium (MEM) with Earle's balanced salt solution 
(EMEM), 10% heat-inactivated fetal calf serum, 2 mM glutamine, 
and no antibiotics unless otherwise noted. 
Virus titrations for PFU were carried out in a methyl 
cellulose overlay medium. The methyl cellulose medium 
consisted of 1% methyl cellulose, MEM with Hanks' balanced 
salt solution, 2 %  fetal calf serum, 2 mM glutamine, 200 
units/ml of penicillin, 100 wg streptomycin/ml and 1 Wg/ml 
of amphotericin B (Fungizone). 
Cells 
Vero cells: African green monkey kidney cells, Vero 
(courtesy of Dr. Byron K. Murray) were used for all virus 
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titrations. Vero cells (2 x 105) were seeded into 16 mm 
wells (24-well Linbro plates). Twenty-four hours later, 
the confluent monolayers were infected with 0. 1 ml of 
serial dilutions of virus and virus allowed to adsorb for 
one hour. The infected cells were then overlayed with 1% 
methyl cellulose medium and incubated at 370C in a 5% CO2 
95% air atmosphere. Forty-eight to seventy-two hours 
later, the cells were fixed by adding a 10% formalin solu­
tion and stained with crystal violet. Plaque-forming units 
were subsequently enumerated. The cells were used at 
passage levels 1-20. 
Mouse embryo fibroblasts: Primary mouse embryo BALB/c 
fibroblasts were seeded into 25 cm2 Falcon flasks and main-
tenance medium added. Once the monolayers were confluent, 
the cells were trypsinized and 1 ml placed into 16 mm wells 
at a concentration of 4 x 105 cells/well for use in anti-
viral assays twenty-four hours later. 
HEP-2 cells: HEP-2, a continuous cell line originally 
derived from a laryngeal epidermoid carcinoma was used for 
the preparation of HSV-2 antigen. These cells (courtesy of 
Dr. B. K. Murray) were serially passed in 75 cm3 Falcon 
flasks and used when the cells were approximately 75% 
confluent. The cells were used at passage levels 10-30. 
Preparation of HSV-2 and HEP-2 Antigen 
HEP-2 cells were seeded into 75 cm2 flasks as de­
scribed above and infected with HSV-2 at a multiplicity of 
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infection of 0 .0 1. The virus was adsorbed for two hours at 
370C followed by washing the monolayers once with Hanks' 
balanced salt solution to remove unadsorbed virus. The 
cultures were replenished with EMEM containing glutamine, 
and antibiotics but without fetal calf serum and incubated 
at 340C. 
When cytopathic effect was determined to be approxi­
mately 70%, the maintenance medium was removed and 1 ml of 
sterile distilled water added to each flask. The monolayer 
was removed with a rubber policeman, the cells collected, 
disrupted by homogenization and centrifuged at 40C 1, 000 
rpm for ten minutes. The supernatant fluids were removed 
and stored at -700C. Portions of each pool were titrated 
on Vero cells. Preparation of the control HEP-2 antigen 
involved the same procedure as discussed above, but without 
infection of the cells with HSV-2. 
The antigen preparations were inactivated by exposure 
to ultraviolet light (General Electric germicidal lamp 
GlST8, IS watt) at 160 ergs/minute/mm2 for six to eight 
minutes and re-titered to determine the presence of any 
infectious virus. If infectious virus was still present in 
the viral antigen preparation, the antigen was heat-inacti­
vated at S60C for ten minutes. 
Inoculation of Mice With Virus 
Mice were inoculated with varying dilutions of virus 
by one of three routes of inoculation. Those inoculated 
intravenously (i.v.) received a total volume of 0. 2 ml of 
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virus dilution in the lateral tail vein. Mice inoculated 
intraperitoneally (i. p. ) received a total volume of 0 . 2  ml 
of the virus dilution in the peritoneal cavity. Mice 
inoculated by the vaginal route received 0. 03 ml of the 
virus suspension directly into the vaginal area using a 
small plastic catheter connected to a 0 . 5  ml syringe 
(Breinig et al. , 1978). 
Recovery of Virus From the Vaginal Area 
Titers of virus in the vaginal area of infected female 
mice were assessed by taking swabs from the area at various 
times after infection. Small cotton swabs on toothpicks 
were moistened with viral diluent and inserted into the 
vagina. The swab was then placed into 1. 0 ml of diluent. 
Titers of virus were expressed at the loglO PFU/ml of 
vaginal suspension. 
Drugs 
Pyran copolymer, lot XA 124-177 was received courtesy 
of Dr. D. Breslow, Hercules, Inc. , Wilmington, DE. The 
drug was prepared by dissolving 2 . 5 mg/ml in 0. 9% NaCl 
solution and adjusting the pH to 7. 0 - 7. 2 with 0 . 1  N NaOH. 
Oyster glycogen No. 2 (Sigma, St. Louis, MO) was prepared 
by dissolving 2 . 5 grams in 100 ml of distilled water. Mice 
were injected i. p. with 0. 5 ml of the glycogen solution 
five days prior to harvesting peritoneal cells. 
Silica No. 12 (particle size 2-10 �m) was obtained 
" 
courtesy of Dr. Benkert (Dorentroper Sand-und Thonwerke 
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" 
GMbH, Dorentroper, West Germany) and prepared by suspending 
the agent in 0 . 9% NaCl at a concentration of 80 mg/ml. 
Immediatel y  prior to use the suspension was sonicated for 
two 5-second bursts. Mice were inocul ated i.p. with 0.5 ml 
of the suspension (80 mg/ml ,  2, 000 mg/kg) two hours prior 
to viral infection. Dextran sul fate (M.W. 500, 000, Serva, 
Heidel berg, Germany) was prepared by dissol ving the com ­
pound in 0 .9% NaCl at a concentration of 1 mg/ml .  Mice 
received S O  mg/kg of the solution i.p. 24 hours prior to 
use. Trypan blue was obtained courtesy of Dr. John Hibbs, 
VA Hospital ,  Sal t  Lake City, UT, at a final concentration 
of 10 mg/ml .  Mice were injected subcutaneousl y with 2 mg 
of the trypan blue 24 hours prior to use (S O mg/kg) fol­
l owed by 1 mg (25 mg/kg) i. p. 2 hours prior to infection. 
Peritoneal Exudate Cel l  Harvesting 
Mice were treated with either pyran or glycogen as de-
scri bed above, or l eft untreated. On day 0, peritoneal 
cel l s  were col lected in the fol l owing manner. Mice were 
sacrificed using chl oroform, secured to a dissection board, 
the peritoneum was exposed, and 10 ml of col d  EM EM without 
fetal cal f serum was injected into the cavity. The fl uid 
was subsequentl y  aspirated. The cel l suspension was cen­
trifuged at 1, 000 rpm at 40C, washed one time and resus­
pended in EMEM containing 10% fetal cal f  serum. 
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Identification of Mononucl ear Phagocytes 
Wright's staining : Mononuclear phagocytes were deter ­
mined morphological l y using the conventional Wright's dif­
ferential stain technique (Fisher Scientific, Pittsburg, 
PA). Smears were made from peritoneal exudate cel l s  and 
fixed for five minutes with methanol. Wright's stain was 
added for three minutes. An equal portion of distil l ed 
water was subsequentl y  added to the slide with gentl e  
mixing, and al lowed t o  stand for six minutes. Slides were 
rinsed and enumerated for the presence of cells of the 
monocytic series. 
Latex particle ingestion : Peritoneal cells (5 x 106/ml) 
suspended in EMEM containing 20 % fetal calf serum were 
placed in 12 x 75 mm plastic tubes and 1 ml of a suspension 
of l atex particl es (Difco, Detroit, M I )  was added to the 
cells. The tubes were placed on a rotor for thirty minutes 
at a speed of 25 rpm at room temperature. Cells were cen­
trifuged for ten minutes at 1, 000 rpm, resuspended in 0.4 ml 
medium and smears made. Slides were stained with Wright's 
stain as described above. Cell s  ingesting greater than 
eight latex particles were considered to be phagocytic and, 
thus, termed "latex positive." 
Stain for nonipecific esterase : Macrophages were also 
characterized on the basis of the presence of a nonspecific 
esterase enzyme activity according to the procedure of Yam 
et al. (1971). The reagents used were as foll ows : 
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Phosphate buffer (0 . 15 M, pH 7. 4) 8. 9 ml 
Hexatozized pararosanilin, 0.6 ml, Sigma Chemical, 
St. Louis 
Alpha-napthyl acetate, 10 mg per 0 . 5  ml ethylene glycol 
monoethyl ether, Sigma Chemical, St. Louis 
4% sodium nitrate solution, 0. 6 ml, Sigma Chemical, 
St. Louis 
Buffered formalin acetone mixture pH 6. 6 
1 %  methyl green solution, Sigma Chemical, St. Louis 
Smears made of PEC were fixed for 20 seconds in the 
buffered formalin acetone mixture at 40C and allowed to air 
dry for thirty minutes. All other reagents except the 
methyl green solution were added to a Columbia jar and the 
final pH adjusted to 5. 8 - 6. 5 with IN NaOH. The fixed 
smears were placed into the Columbia jars and allowed to 
incubate in the mixture for 45 minutes at room temperature. 
The smears were then washed in distilled water and counter-
stained with 1% methyl green stain for 1-2 minutes, washed 
and air-dried and mounted onto slides with Permount. The 
presence of the esterase ac tivity was noted as the appear-
ance of red granules within the cytoplasm of the cell, and 
termed esterase positive. 
Basic Assay for Delayed Type Hypersensitivity in Mic e 
Mice were infe cted i. v. or intravaginally with an LD50 
inoculum of HSV-2. At various times following infection, 
the mice were c hallenged in one hind footpad with 0.05 ml of 
UV light - inac tivated HSV-2 antigen (original titer 5 x 107 
plaque-forming units/ml). Control HEP-2 antigen was injected 
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into the contralateral footpad. Uninfected mice were 
treated in a similar manner. At twenty-four hours after 
antigen inoculation, footpad swelling was quantitated by 
measurement with a caliper and compared with footpad mea-
surements prior to inoculation with antigen. Measurements 
of footpad swelling in infected animals were compared with 
those of the uninfected group. Swelling in the footpad 
receiving the HSV-2 antigen was also compared with the 
contralateral foot receiving control antigen. Histological 
examination was performed to determine the nature of the 
inflammatory response. 
r 125 lb . A f D I d T -a umln ssay or e aye ype Hypersensitivity 
Another method to assay for delayed hypersensitivity 
in mice to HSV-2 involved a modification of the assay re-
ported by Paranjpe (1972). The assay involved inoculation 
of antigen into the footpads as previously discussed. 
Twenty-four hours following antigen challenge, 0.2 ml of 
r 125-labelled human serum albumin (Mallinckrodt, St. Louis, 
MO), specific activity 0.1 mc/ml was injected i. p. Two 
hours following injection of the albumin, both feet were 
amputated just below the hackle joint and placed into a 
gamma counter to determine the amount of radioactivity. A 
stimulation ratio was derived by comparing the amount of 
radioactivity in the hind foot challenged with HSV-2 antigen 
with the foot receiving control antigen of each individual 
mouse. 
s r  cpm in left hind footpad cpm in right hind footpad 
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Basic Assay for Antiviral Activity of Peritoneal Exudate 
Cells In Vitro 
Vero or secondary mouse embryo fibroblasts were seeded 
in 16 mm Linbro plates as discussed previously. Twenty-four 
hours later, the confluent monolayers were infected with 30-
50 PFU of HSV-2 and virus adsorbed for two hours. Following 
virus adsorbtion, various concentrations of peritoneal cells 
were added to the infected controls and allowed to adhere 
for two hours. At this time, nonadherent cells were removed 
by washing the monolayers three times with Hanks ' balanced 
salt solution and then EMEM or methyl cellulose overlay 
media containing 10% fetal calf serum and antibiotics were 
added. Cultures were incubated for forty - eight to seventy­
two hours at 360C in 5% CO2 atmosphere. Supernatant fluids 
were removed at daily intervals and titered on Vero cells 
to determine levels of extracellular virus. The monolayers 
were fixed with formalin and stained with crystal violet for 
plaque enumeration. In each experiment, in addition to the 
test PEC group, there was also a group of cells receiving 
virus alone, and a group that received normal PEC (from mice 
inoculated i. p. with 0. 2 ml of physiological saline at the 
same time as virus was inoculated). Toxicity controls were 
performed to determine any toxic ef fect that the peritoneal 
cells were exerting on uninfected target cells. 
Peritoneal Cell Transfer 
Donor mice were either treated with pyran or glycogen 
or left untreated. At day 0, peritoneal cells (PEC) were 
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harvested as described previously and resuspended to a final 
concentration of 1. 5 x 107 PEC/ml. This cell suspension 
(0.2 ml) was injected i. p. into one to seven day old suck-
ling mice. Twenty-four hours later, the suckling mice were 
challenged with HSV-2 intraperitoneally and mortalities 
recorded. 
Virus Neutralization 
Serum suspected of containing HSV-2 antibody was heat 
inactivated for 30  minutes at 560C. Serial two-fold dilu-
tions of the serum were incubated with a constant dilution 
of virus (approximately 4 0  PFU) and 20 hemolytic units of 
guinea pig complement (Colorado Serum Co. , Denver, CO) for 
30 minutes at 370C. Each dilution (0. 1 ml) was subsequently 
titrated on Vero cells to determine reduction in PFU. The 
titer of specific neutralizing antibody was expressed as the 
reciprocal of the dilution causing 50 % plaque reduction as 
compared to cultures containing no antibody. Control 
+ 
rabbit anti-HSV-2 serum of known titer (1480 units - 188) 
was always run as a control (Breinig et al. , 1978). 
Preparation of Pathological Sections 
Pathological sections of the footpad were prepared and 
stained with hematoxylin-eosin courtesy of Dr. Michael 
Snodgrass. 
Statistical Analysis 
Significant differences (p<0. 05) among control and 
experimental groups were determined by using the Student 
34 
t - t e s t . The L D S O  o f  t h e  v i ru s  was  de t e rm in e d  u s i n g  the 
me t ho d  of R e e d  and Muench ( 1 9 3 8 )  w i t h  Ya t e s  c o r r e c t i o n  
fac t o r . 
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RESULTS 
A. C e l l - Me d i a t e d  I mmun i t y  D u r i n g  HSV I n fec t ion Demons t ra t e d  
by D e l ay e d - Typ e Hyp e r s en s i t iv i t y  
Cha r ac t e r i s t i c s  o f  t h e  d e l aye d - t ype hype r s en s i t i v i ty 
( DTH)  r e spo n s e  t o  HSV - Z  ant igen . A f o o t p a d  swe l l ing a s s ay 
wa s deve l o p e d  t o  m e a s u r e  t he i n  v i vo DTH a s p e c t  o f  t h e  c e l l ­
me d i a t e d  immun e r e sp o n s e  t h a t  d e v e l o p e d  in m i c e  infe c t e d  
i . v .  w i t h  an L D 5 0  o f  HSV - Z .  The s p e c i f i c i ty o f  t h i s  a s s ay 
was  demon s t rat e d  by t h e  ab i l i t y  o f  m i c e  i n f e c t e d  1 4  days 
p r e v i ou s l y  w i t h  HSV - Z t o  r e spond s i gn i f i c ant l y  to  t h e  HSV - Z  
ant i g en , but not  to  c o n t r o l  ant i g en (HEp - Z ) (Tab l e  1 ) . The 
HEp - Z  ant i g en was c h o s e n  as t he c on t r o l an t i g en s in c e  the 
v i rus  u s e d  for  i n o cu l a t i o n  was  propa g a t e d  in v i t ro in HEp - Z  
c e l l s .  Thus , t h e  u s e  o f  HEp - Z  a s  a c o n t r o l  ant i g en wou l d  
d e t e c t  r e spon s e s  wh i c h  may have o c c u r r e d  a s  a r e s u l t  o f  in 
v i vo s en s i t i z a t i o n  w i t h  HEp - Z  s p e c i f i c  ant i g en . 
Four g r o up s  o f  m i c e , two g roups o f  un i n f e c t e d  and two 
g roups o f  H SV - Z  i n fe c t e d  m i c e  r e c e i v e d  e i t h e r  HSV - Z ant i g en 
or c o n t r o l  ant i g en in the l e f t  h i n d  f o o t p a d  wh i l e  the r i ght 
h ind foo t p a d  r ema i n e d  uninocu l a t e d  ( Tab l e  1 ) . A s t imu l a t ion 
r a t io  w a s  d e r i v e d  by d i v i d in g  t h e  c o unt s per  m inute o b t a ined  
from t he inocul a t e d  food  with  t h e  c o unt s p e r  minute o f  t h e  
un inocu l a t e d  f o o t  in e a c h  ind i v i du a l  mou s e . T h e  on l y  g roup 
t h a t  showed a s i gn i f i c an t  r e s pon s e  in e i t h e r  the foo tpad 
s we l l in g  or t he r a d i o i s o t op i c DTH a s s ay was t he group o f  
m i c e  i n fe c t e d  w i t h  HSV and cha l l e n g e d  w i t h  t h e  HSV ant i g e n . 
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TAB L E  1 
Comp a r i s o n  o f  F o o t p a d  Swe l l i n g  and Rad i o i s o t o p i c  
As s ay t o  Me a s u r e  Spec i f i c i t y  o f  De l ayed 
Typ e Hyp e r s en s i t i v i ty R e s p o n s ea 
I n fe c t ion F o o tpad Ch a l l en g e  
I n c r e a s e  in b F o o tp*d w i t h  
MS R "!: o f  M i c e  W i t h  ( mm - S E )  
H EP - 2  Ag 1 .  0 2  + 0 . 1 2 0 . 0 3 + None - -
H SV - 2 1 . 1 4 + 0 . 0 5 + Ag - 0 . 1 0 -
+ 0 . 0 9 + H SV - 2  HE P - 2  Ag 1 .  0 5  - 0 . 0 5 -
HSV - 2 Ag 1 .  7 4  + 0 . 1 8 d 0 . 4 0 + - -
SEc 
0 . 0 2 
0 . 0 3 
0 . 0 2 
0 . 0 4 d 
aBAL B / c  m i c e  we r e  un t r e a t e d  o r  i n f e c t e d  int ravenous l y  w i t h  
HSV - 2  wh i c h  c au s e d  5 0 - 7 0 %  mo r t a l i ty .  Fourteen  days l a t e r  
r i ght h in d  f o o t p a d s  w e r e  inocul a t e d  w i t h  t h e  ant i g en ind i ­
c a t ed . Twen t y - four h o u r s  l at e r  f o o t p a d  t h i c kne s s  o f  t h e  
r Z �r f o o t p a d s  w a s  m e a s u re d , fo l l owe d by inocul a t i o n  w i t h  
I - a l bumin i n t rape r i t one a l l y . Aft e r  2 hour s , f e e t  w e r e  
exc i s e d  j us t  b e l ow t he hac k l e  j o int a n d  amount o f  radio ­
a c t i v i t y  ana l y z e d  i n  a g amma c o un t e r .  
b I n c r e a s e  i n  f o o t p a d  t h i ckne s s / w i d t h  b e t we e n  inocul a t e d  
r i ght and un inoc u l a t e d  l e f t  footpad . The r e  w e r e  1 0  m i c e  
p e r  group . 
cMSR = mean s t imu l a t i o n  r a t i o  
c o un t s pe r  m inute  i n  r ifht hind footpad 
c o un t s p e r  minut e ln I e  t hind fo o t p ad 
dp < 0 . 0 5 o f  ino cu l a t e d  comp a r e d  t o  un inocu l a t e d  footpad o r  
comp a r e d  t o  HSV - i n f e c t e d  mou s e  f o o t p a d  c ha l l en g e d  w i th 
HEP - 2  Ag , o r  un in f e c t e d  mo u s e  f o o t p a d  c ha l l en g e d  w i th 
HE P - 2  o r  HSV - 2  ant i g e n  
3 7  
Tabl e 1 a l s o d emon s t r a t e s  t h a t  t h e  r ad i o i s o t o p i c  a s s ay 
c o r r e l a t e d  we l l  w i t h  m e a s u r ement o f  footpad swe l l in g  me a ­
s u r e d  2 4  hours a ft e r  ant i gen c ha l l en g e . Th e r e  we r e  no 
s i gn i f i c an t  i n c r e a s e s  in f o o t p a d  t h i c kne s s  o r  s t imu l a t ion 
r a t i o s  i n  t h e  footpads  of  no rma l mice  inocul a t e d  with HSV - 2  
o r  cont r o l  an t i g e n  o r  HSV i n f e c t e d  m i c e  ino c u l a t e d  w i th 
cont ro l ant i g en . Thus , in subs e quent e xp e r imen t s , g roups 
were c o n s o l i d a t e d  such t h a t  one g r o up of un i n f e c t e d  anima l s  
and one g r oup o f  i n fe c t e d  an ima l s  woul d r e c e i v e  HSV - 2  
ant i gen in t h e  l e ft  h ind f o o t p a d  and cont ro l ant i gen in the 
r i g h t  h ind f o o t p a d . 
A s e cond a s p e c t  o f  t h e  s y s t e m  was  t o  d e t e rmine the op ­
t imal t ime fo r p e a k  r e s p o n s i ve n e s s  fo l l owing  ant i g e n  cha l ­
l en g e . The app e arance o f  t h e  o p t imal r e s p o n s e  fo l l owing  
an t i g en c ha l l en g e  i n  t h e  f o o t p a d  was  typ i c a l  of  t h e  usual  
DTH r e spon s e  ( Tab l e  2 ) . The mean s t imu l a t ion rat i o  wa s 1 . 1 1 
a t  6 hr , max imal ( 1 . 5 8 )  a t  2 4  h r s , and wan e d  ( 1 . 1 2 )  by 4 8  
h r s  a f t e r  ant i gen c h a l l en g e . Aga i n , un infec t e d  m i c e  s howed 
no s i gn i f i c an t  r e spon s e  d u r i n g  t h e  6 - 4 8 hour p e r i o d . 
S t a t i s t i c a l  ana l y s i s  o f  v a r i an c e  r e ve a l e d  t ha t  t h e r e  w e r e  no 
s t at i s t i c a l  d i ff e renc e s  i n  the footpad r e spon s e  among the 
g ro up s  o f  n o rmal a n i ma l s  among the va r i o u s  e xp e r iment s .  
Thu s , t h e  u n i n fe c t e d  an ima l s  from e a c h  e x p e r iment were  
p o o l ed t o  provide  a c omb ined  c ont r o l  g roup for comp a r i son 
w i t h  the v a r i ou s  g ro up s  of m i c e  i n fe c t e d  int r avenous l y  w i t h  
HSV - 2 .  
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TAB L E  2 
Op t imum DTH R e s po n s e  o f  M i c e  t o  HSV - An t i g en 
Cha l l en g e  14 Days Aft e r  IV I n f ec t i on a 
Ho urs  A f t e r  An t i g enb Cha l l en g e  ( M S R  - S E )  
I n f e c t ion 
of  M i c e  6 2 4  4 8  
None 
+ 1 . 0 0 - 0 . 0 7 
HSV - 2 1 . 1 1 -: O . l 1 d 
1 . 1 0 -: 0 . 0 5 
1 . 5 8 -: O . O S c 
1 . 0 9 -: 0 . 0 7 
1 . 1 2 -: 0 . 0 8 d 
a BAL B / c  m i c e  we r e  e i t h e r  unt r e a t e d  o r  i n fec t e d  i . v .  w i t h  
HSV - 2 wh i c h  c au s e d  5 0 - 7 0 %  mo r t a l i t y .  F o ur t een days l a t e r  
t h e i r  r i gh t  hind  f o o t p a d s  we re inocu l a t e d  w i t h  c o n t r o l  
HE P - 2 a n t i g en a n d  t he l e ft  h ind fo o tp a d s  inocul a t e d  w i t h  
HSV - 2 an t i gen . Twen t y - four hours a f t e r  ant i � z �  chal l en g e , 
m i c e  we r e  i n o c u l a t e d  i n t r ap e r i t o n e a l l y  w i t h  I - a l bum in . 
Two hour s  l a t e r  t h e  l e f t  and r i g h t  h i n d  foo t p a d s  we r e  
removed j us t  b e l o w  t he ha c k l e  j o i n t  a n d  c ou n t e d  in a 
gamma c o un t e r . 
bMSR = mean s t imu l a t i o n  r a t io  
c o un t s pe r  m in u t e  in l e ft h i n d  f o o tpad 
c o un t s  per  minut e ln r i ght hind fo o t pad 
cp < . 0 5 a s  c omp a r e d  w i t h  un i n fe c t e d  m i c e  a t  e i t h e r  6 ,  2 4 , 
o r  4 8  hours . 
d N . S .  = n o t  s i gn i f i c an t  a s  c omp a r e d  w i t h  un infe c t e d  
m i c e  a t  e i t h e r  6 ,  2 4 , o r  4 8  hours a f t e r  ant i g en cha l l en g e . 
F I GURE lA : 
39 
H i s t o l o g ical  s e c t ion o f  a hind fo o t p a d  from 
an un infe c t ed mouse  24 hours a f t e r  r e c e iving 
HSV - 2  ant i g en in the footpad . 
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F I GURE l B : 
4 1  
H is t o l o g i ca l  sect ion from the hind  foo tpad 
of a mice infected int ravenous l y  on day - 6  
and chal l enged with  HSV - 2  ant i g e n  in the 
footpad on day o .  Twenty - four ho urs lat e r  
pa tho l o g i ca l  se c t i ons we re  made . No t e  the 
dense c e l lular inf i l t rat es . 
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H i s t o l o g i c a l  examinat ion wa s a l s o p e r fo rme d on fo o tpad 
s e c t i o n s  of  b o t h  un i n fe c t e d  and i n f e c t e d  mice  t o  det e rmine 
t h e  nature of t he i n f l amma t o ry r e s p on s e  2 4  hours fo l l ow i n g  
ant i g en c ha l l en g e . F i gure  lA r ep r e s ent s a s e c t ion f r o m  a n  
u n i n fe c t e d  mo u s e  r e c e iv in g  H SV - 2  ant i g en in t h e  footp ad . 
Th e re i s  l i t t l e  e v i denc e o f  c e l l u l ar in f i l t r at i on o r  ne -
c ro s i s o f  t i s s ue . I n  c o n t ra s t , howeve r ,  in a mo u s e  p r e -
v i ous l y  i n fe c t e d  t h e r e  was  a comp a r a t i ve l y  l a r g e r  d e g r e e  o f  
c e l l u l a r  in f i l t ra t i o n  in t h e  fo o t p a d  r e c e i v i n g  HSV - 2 ant i g en 
( F i g .  l B ) . Th i s  c e l l u l a r  i n f i l t ra t e  was comp o s e d  p r ima r i l y  
o f  mononuc l e a r  c e l l s .  Thus , t h e  h i s t o l o g i c a l  data p ro v i d e d  
s uppo r t  f o r  t h e  p r e s en c e  o f  a s p e c i f i c  D T H  r e s p o n s e  in t h e  
footpads  o f  i n fe c t e d  m i c e . 
K i ne t i c s  o f  t h e  DTH r e spo n s e  i n  m i c e  infe c t e d  intrave ­
no u s ly w i t h  H SV - 2 .  On c e  t h e  opt imal c o nd i t i o n s  for the a s ­
s ay we r e  e s t ab l i s h e d , t h e  k ine t i c s  o f  t h e  DTH r e sponse  were  
d e t e rm i n e d  fo l l ow i n g  i . v . i n fe c t ion of  BAL B / c  mice  infe c t e d  
i n t r avenous l y  w i t h  H SV - 2  ( F i g . 2 ) . A s i g n i f i c ant DTH re ­
s p o n s e  wa s no t o b s e rved e a r l i e r  t han 4 days a f t e r  infe c t ion . 
By day 6 a re s p o n s e  wa s o b s e rve d .  The mean r e sponse  wa s 
s i gn i f i c an t l y  e l e va t e d  o v e r  c o n t r o l  l e ve l s  on days 7 ,  1 0 , 
and 1 4 , b e gan t o  d e c l i n e  by 1 9  days  a f t e r  infec t i on , and 
v i r t ua l l y  d i s ap p e a r e d  by day 7 0 . 
A c r i t e r i on wa s e s t a b l i s hed t o  d e t e rm ine what wa s con ­
s i d e r e d  t o  be a po s i t i v e  s t imul at i o n  r a t i o  in an i n d i v i dual 
an imal . A t o l e rance i n t e rval wa s e s t a b l i s hed such that a 
s t imu l a t ion r a t i o  o f  1 . 3 2 o r  g r e a t e r  i n  an ind i v i du a l  mo u s e  
F I GURE 2 :  
4 4  
Kine t i c s  o f  t h e  appearance o f  t h e  d e l ayed 
type hyp e r s ens i t iv i ty r e sp o n s e  fo l l owing 
intravenous infec t i on with HSV - 2 .  BAL B / c  
mice we re  infec t e d  w i t h  HSV - 2  and a t  various 
t imes after infe c t ion t h e  DTH re sponse 
measured us ing t h e  rad i o i s o top i c  fo o tpad 
method as p r ev i ous l y  d e s c r i be d .  The shaded 
area rep r e s e nt s t h e  DTH re spons e s  o f  no rmal 
un infe c t e d  m i c e  wh i l e  the conne c t e d  l in e s  
repre s en t  p a t t erns o f  DTH re spons i vene s s  i n  
HSV - 2 infec t ed mice  a t  v a r i o u s  i n t e rva l s  
fol lowing infect ion . 
MSR + S . E . C PM in C PM In 
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was  co ns i d e r e d  t o  b e  a po s i t ive DTH r e spon s e . I n  t e rms o f  
p e r c ent a g e s o f  i n fe c t ed m i c e  g i ving  a p o s i t ive respon s e , 8 0 %  
o f  t h e  m i c e  s howed a po s i t ive r e sponse  by day 6 ,  wh i l e by 
day 1 9  onl y 5 0 % , and on day 7 0  none o f  t h e  m i c e  e l i c i t e d  a 
p o s i t ive DTH r e s p o n s e . 
K i ne t i c s  o f  t he DTH r e spon s e  fo l l owing int ravaginal 
i n fe c t i o n  w i t h  H SV - 2 .  E x p e r imen t s  s im i l a r to  t h e  int rave ­
nous i n f e c t ion were  p e r fo rmed w i th m i c e  infe c t e d  intra ­
vag ina l l y  w i t h  H SV - 2  ( F i g . 3 ) . S i m i l a r  t o  t h e  int ravenous 
i n f e c t i o n , no r e s p o n s e  was  d e t e c t e d  as e a r l y  a s  4 days p o s t ­
i n f e c t ion . A p o s i t iv e  r e s p o n s e  app e a r e d  by day 7 ,  and was 
ma i n t a ined  w i t h  anima l s  r e s p ond ing ma x ima l l y  on day 1 4 , but 
b e c ame unde t e c t ab l e by day 2 3 .  I t  app e a r e d  t h a t  the DTH r e ­
s p o n s e  fo l l ow i n g  v a g i n a l  infec t i on wa s chara c t e r i z e d  by a 
mo r e  t r an s i ent r e s p on s e  t h an t h a t  fo l l ow i n g  s y s t e m i c  infe c ­
t ion . 
At t e mpt s  t o  c o r r e l a t e  a po s i t i ve DTH r e spo n s e  w i t h  
surv ival  during HSV i n fe c t ion . At t e mp t s  were  made to  de t e r ­
m i n e  i f  a c o r r e l a t ion e x i s t ed b e t ween t h e  p r e s ence  o f  a DTH 
r e s po n s e  and survival  o f  t h e  anima l . I n  t h e s e  exper iment s ,  
f o o t p a d  swe l l in g  wa s u s e d  t o  d e t e rm ine t h e  p r e s ence  or ab ­
s en c e  o f  a DTH r e s p o n s e  on day 6 fo l l owing int ravenous 
i n fe c t ion . The ind i v i du a l l y  ma rked anima l s  were then fo l ­
l owed for  survival  ( Tab l e 3 ) . T h e r e  wa s no app arent c o r r e ­
l a t ion be tween a po s i t i ve DTH r e s p o n s e  on day 6 and surviva l . 
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F I GURE 3 :  Kine t i c s  o f  t h e  appearance o f  t h e  d e l ayed 
type hyp e r s e n s i t i v i t y  re sponse fo l l owing 
int rava g inal infec t i on w i th HSV - 2 .  BAL B / c  
m i c e  w e r e  infec t ed w i t h  HSV - 2 a n d  a t  various  
t imes a ft e r  infec t i on the DTH response  me a -
s ured us ing the rad i o i s o t op i c  foo tpad  me thod 
a s  p revious l y  de s c r i be d .  
MSR + S . E .  C PM in C PM In 
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Ap p r o x ima t e l y an e qu a l  p ropo r t i o n  o f  an i ma l s  demon s t rat i n g  a 
p o s i t ive DTH r e s p o n s e  s urvived ( 8 / 1 3 )  a s  s ucc umb e d  ( 5 / 1 3 )  t o  
t h e  HSV i n f e c t i on . 
B .  Ro l e  o f  Ma c ro p h a g e  i n  Re s i s t an c e  t o  HSV 
E f fe c t s  o f  mac rophage d epl e t ion in v ivo on s u s c ept i ­
b i l i ty o f  m i c e  t o  i . v . i n fe c t ion w i t h  HSV - 2 .  We comp a r e d  
t h e  e f fe c t  o f  admin i s t ra t ion o f  t h r e e  d i f fe r en t  a gen t s ,  
known t o  i mp a i r  mac ropha g e  func t ion , on the r e s i s t ance t o  
s y s t em i c  ( i . v . ) o r  l o c a l  ( in t ravag ina l )  infec t ion w i t h  HSV -
2 .  
M i c e  w e r e  p r e t re a t e d  w i t h  one o f  t h e  t h r e e  mac rophage 
i nh i b i t o ry a g e n t s ( s i l i c a , t rypan b l ue , or dext ran sul fat e )  
a s  d e s c r i b e d  i n  T ab l e  4 .  The d r u g s  admin i s t e re d  i n  the ab ­
s e n c e  o f  i n fe c t i o n  w i t h  HSV - 2  w e r e  n o t  t o x i c  t o  the anima l s  
a t  t h e  g iven d o s a g e s . 
Charac t e r i z a t i on o f  t h e  e f fec t s  o f  t h e  t r e a tmen t s  on 
e s t e r a s e  po s i t i v i t y  and l a t e x  p a r t i c l e  in g e s t ion of the 
p e r i t o n e a l  c e l l s  r e ve a l e d  t h a t  s i l i c a  t re a tment r e s u l t e d  in 
t he g r e a t e s t  d e c r e a s e  i n  p e r c e n t a g e  of e s t e r a s e  and l a t e x  
p o s i t ive  c e l l s  ( 3 1 %  i n  c o n t ro l s  vs 8 %  in s i l i c a  t r e a tment ) .  
Al l t h r e e  a g e n t s  a l s o c au s e d  an inc r e a s e  in the p e r c e n t a g e  
o f  p o l ymo rphonuc l e � r  neut roph i l s  in t h e  p e r i t o n e a l  cav i t y , 
p r o b a b l y  due t o  a n o n s p e c i f i c  i n f l amma t o ry r e spon s e . In  
t e rms of  c e l l  y i e l d s  the  l a r g e s t  o b s e rv e d  e ff e c t  wa s seen 
w i t h  t rypan b l ue , wh i c h  caused a 2 - fo l d  d e c r e a s e  in c e l l  
numb e r  a s  c o mp a r e d  t o  c o n t r o l  m i c e  ino c u l a t e d  w i t h  s a l ine . 
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TABLE 3 
Lack o f  C o r r e l a t i o n  o f  t h e  D e l ay e d  Typ e Hyp e r s en s i t i v i t y  
Re s p on s e  o n  Day 6 W i t h  Survival  A f t e r  I n t ravenous 
I n f e c t i o n  w i t h  HSV - 2 a 
De l aze d TZEe HZEe r s en s i t i v i tz Re sEo n s e  
Po s i t iv e  Negat ive 
Exp e r imen t Surv i v e d  D e a d  Survived Dead 
1 2 3 2 1 
2 6 2 1 1  1 
T o t a l  8 / 2 8  5 / 2 8  1 3 / 2 8  2 / 2 8  
% Ag e 2 9 %  1 8 %  4 6 %  7 %  
aM i c e  we r e  i n f e c t e d  i n t raveno u s l y  w i t h  HSV and on day 6 
inocul a t e d  i n  t h e  l e ft h ind foodpad w i t h  HSV - 2  ant i g e n  
and in  t h e  r i g ht h ind f o o t p a d  w i t h  H E P - 2  ant i g en .  
Twent y - four hour s l a t e r  h ind f o o t p a d s  we r e  measured  w i t h  
a c a l i p e r .  
TABL E  4 
E f fe c t s  o f  Mac r o p h a g e  I nh i b i t o ry A g en t s  o n  P e r i t on e a l  C e l l  Popul a t i o n s a 
Regimen Numb e r  o f  
(%2 b 
P e r c en t C 
Do s e- Rout e Time P e r i t on e a e D i f f e r en t i a l  E s t e r a s e  + L a t e x  
T r e atment (mm/ k g )  ( h r ) C e l l s  ( x l O ) Mono L ymph PMN Po s i t i v e  C e l l s  
Sa l in e  i . p .  2 . 1  2 9 : 1 6 5 : 1 6 : 1 3 2 : 2 
S i l i c a  2 0 0 0  i .  p .  - 2  2 . 0  7 : 3 2 3 : 3 6 9 : 1 8 : 2 
D e x t ran 
2 7 : 6 2 3 : 2 5 0 : 5 1 5 : 1 Sul fa t e  5 0  i . p .  - 2 4 3 . 0 
Trypan 
1 5 : 2 6 2 : 4 2 2 : 5 2 0 : 1 B l u e  5 0  s . c .  - 2 4 1 . 0  
and 
2 5  i .  p .  - 2  
aM i c e  we r e  t r e a t e d  w i t h t h e  macrophage  i nh i b i t o ry a g e n t s  at the do s e s  and t ime s i n d i c a t e d  
pr i o r  t o  o b t a in in g  p e r i t o n e a l  c e l l s . The p e r i t on e a l  c e l l s  w e r e  t h en r e moved and ana ­
l y z e d  f o r  numb e r  and type o f  c e l l s  p r e s en t . 
bMo no = monocy t e ; l ymph = l ympho c yt e ; and PMN p o l ymo rphonuc l e a r  l eukoc y t e  a s  d e t e rmined 
by m i c r o s c o p i c  exam i n a t i o n  of  Wr i ght ' s  s t a in e d  smea r s . 
cA s  d e t e rm i n e d  by d e t e c t i o n  o f  n o n s p e c i f i c  e s t e r a s e  en z yme ac c o r d i n g  to  t h e  method o f  




On d a y  0 ,  m i c e  we r e  inoc u l at e d  i . v .  w i t h  va r i ous  d i l u ­
t io n s  o f  HSV - 2 .  Th e L D S O wa s c a l cu l a t e d  us i n g  the method o f  
R e e d  and Muench ( 1 9 3 8 ) . Th e r e  wa s gene r a l l y  a ten - fo l d  o r  
g r e a t e r  inc r e a s e  i n  t h e  L D S O i n  e a ch o f  t h e  t r e a t e d  group s  
a s  compa r e d  t o  t h e  unt r e a t e d  g roup s  (Tab l e  S ) . 
E f fe c t  o f  macrophage inh i b i t o ry agent s on vaginal 
H SV - 2 i n fe c t i on . M i c e  w e r e  t r e a t e d  w i t h  t h e  a g en t s  a s  de ­
s c r i b e d  a b o ve but i n f e c t e d  va g in a l ly w i t h  HSV - 2 (Tab l e  S ) . 
I n  c on t r a s t  t o  t h e  r e s u l t s  o b t a i n e d  w i t h  i . v .  i n f e c t i on , 
s i l i c a , t rypan b l ue , and d e x t ran s u l fa t e  had no e f fect on 
t he s u s c e p t i b i l i t y  o f  m i c e  to va g in a l  i n f e c t i o n  a s  comp a r e d  
t o  unt r e a t e d  c on t ro l s . T i t e r s  o f  v i ru s  rec ove r e d  in t h e  
va g in a l  s e c r e t i o n s  we r e  a l s o  mon i t o r e d  l n  m i c e  infec t e d  by 
t h i s rout e . A l l  m i c e  s h o w i n g  e v i dence  of v i ru s  in va g in a l  
s e c re t i o n  eventua l l y s uc c umb e d . F i gure 4 i l l u s t r a t e s  the 
l o g l O g e o me t r i c m e an t i t e r  of t h e  t r e a t e d  g roup s and con ­
t ro l s . No  s i gn i f i c an t  d i f f e r e n c e s  w e r e  o b s e rved in  t i t e r s  
o f  va g in a l  v i r u s  in  t h e  t r e a t e d  v e r s u s  unt r e a t e d  g r o up s . 
Thu s , the l ac k  o f  e f f e c t  o n  l e t ha l i t y  by t re a tment w i t h  
t he s e  compoun d s  c o r r e l a t e d  w i t h t h e  l a ck o f  e f fect  o n  l o c a l  
v i ru s  g rowth in  t h e  vag ina l a re a .  I n  s ome s u r v i v ing m i c e , 
s e rum w a s  t e s t e d fo r n e u t r a l i z in g  ant i b o dy ac t i v i ty . 
An t i body l e ve l s  we r e  n o t  marke d l y  a f f e c t e d  by t r e a tment w i t h 
s i l i c a , t rypan b l u e , o r  d e x t ran s u l fa t e . 
I n  v i vo ant i v i r a l  a c t i v i ty o f  pe r i t on e a l  exud a t e  c e l l s .  
John s o n  ( 1 9 6 4 )  r ep o r t e d  r e s i s t ance t o  i n fe c t i on wi th HSV in ­
c re a s e d  w i t h  i nc r e a s i n g  a g e . Th i s  a g e  fac t o r  was found to  
TABL E  5 
E f f e c t  o f  T r e atment o f  M i c e  W i t h  Mac r o p h a g e  I nh i b i t o r y  
Ag ent s on  I n t ravenous  o r  V a g i n a l  HSV - 2  I n fe c t i on a 
LOG 1 0  L D 5 0 / O . 2  ml  
I n f e c t i on Mou s e  St r a in S a l i n e  S i l  i c a  DxS04 Trypan B l ue 
1 .  V .  BAL B/ C 4 . 4  5 . 5 ( 1 . 1 ) b N Dc N D  
BALB/ C 2 . 9  4 . 2  ( 1 . 3 ) 3 . 8 ( 0 . 9 ) 4 . 4  ( 1 . 5 )  
BAL B/ C  1 . 6  3 . 6 ( 2 . 0 )  2 . 9  ( 1 . 3 ) 2 . 7  ( 1 . 1 ) 
C DF l 2 . 1  2 . 9  ( 0 . 8 )  2 . 4  ( 0 . 3 ) 3 . 4  ( 1 . 3 )  
V a g i n a l  BAL B/ C 2 . 5  2 . 5  ( 0 )  N D  N D  
BALB/ C 1 . 1  0 . 8  ( 0 . 3 ) 0 . 9  ( 0 . 2 ) 0 . 7  ( 0 . 4 ) 
aM i c e  we r e  t r e a t e d  w i t h  t h e  mac ropha g e - inh i b i t o ry a g e n t s  a s  d e s c r i b e d  i n  
Tab l e  4 a n d  in f e c t e d  i . v .  o r  vag ina l l y w i t h  d i l ut i o n s  o f  HSV - 2 ,  mo r t a l i t y 
r e c o r de d , and t h e  5 0 %  l e t ha l i t y  endpo i n t  ( L D 5 0 ) c a l c u l a t e d . 
b Numb e r s  in  p a r en t h e s e s  i n d i c a t e  LOG 1 0  d i f fe r e n c e  from con t ro l . 
c ND , not  d e t e rmin e d . 
VI 
VI 
F I GURE 4 :  
S 4  
Loca l rep l icat ion o f  HSV - 2  in t h e  va g in a l  
area . M i c e  we re  t r e a t e d  w i t h  the mac ropha ge  
inhibitory ag ent s a s  d e s c r i b e d  in Mat e r i a l s  
and Me tho d s , i n f e c t e d  int rava g ina l l y  wi th 
HSV - 2 ,  and vag inal swabs t aken d a i l y  for 
d e t e rminat ion of v i ru s  t i t e r s . Each va l ue 
i s  the geome t r i c  mean t i t e r  o f  t i t e r s  from 
s everal  i n d i v idual  m i c e . 0 ,  C o n t ro l ; 
I ,  Trypan b l u e  t r e a t e d ; S i l i c a  t r e a t e d ; 
, D e x t r an su l fa t e  t r e a t e d . 
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b e  a t t r i bu t ab l e  t o  t h e  l a ck o f  a popul a t i o n  o f  mature 
m a c r opha g e s  in newb o r n  m i c e . Thus , the s u c k l i n g  mou s e  
s e r v e s  a s  an  app r o p r i a t e  mo d e l  o f  anima l s  natura l l y  de f i ­
c i ent  i n  ma c ro p h a g e  func t io n  and i s  u s e fu l  fo r d e t e r m i n i n g  
t h e  e ff e c t  o f  macro pha g e s  o n  r e s i s t ance fo l l ow i n g  HSV 
i n fe c t i o n . 
The ant i v i ra l  e f f e c t  o f  pyran - ac t i v a t e d  o r  g l yc o g en ­
e l ic i t e d  p e r i t on e a l  exud a t e  c e l l s  wa s a s s e s s e d  by d e t e rm i n ­
i n g  t he p ro t ec t ive a b i l i t y  o f  p a s s i v e  t r an s f e r  o f  t h e s e  
c e l l s  i n t o  s uc k l i n g  m i c e  ( Ta b l e  6 ) . M i c e  1 - 4  day s o f  a g e  
r e c e i v e d  e i t h e r  p e r i t o n e a l  c e l l s f r o m  pyran , g l yc o g e n , o r  
s a l ine - t r e a t e d  adul t m i c e  o r  we re l e ft  unt re a t e d . On day 0 
t he neon a t a l  m i c e  we re i n f e c t e d  wi th HSV - 2  and mo r t a l i ty 
r e c o rde d . T h e r e  w a s  a s i gn i f i c ant d i f f e r en c e  b e t we en the 
mo r t a l i t y  o f  t he g r o up p a s s i ve l y  t re a t e d  w i t h  pyran - ac t i ­
va t e d  P E e  a s  c omp a r e d  w i t h  t h e  un t r e a t e d  g roup or  the group 
t re a t e d  w i t h  no rma l p e r i t o n e a l  ce l l s .  Tran s fe r  o f  g l yc o g en 
p e r i t o n e a l  exuda t e  ce l l s  s howed s l i gh t , but i n s i g n i f i cant 
p r o t e c t i o n . Th e r e  w e r e  no s i g n i f i c ant d i f fe r enc e s  in the 
mean s u r v i v a l  t ime of m i c e  that d i e d , wh i c h  i n  the unt r e a t e d  
g r o up wa s 7 . 4 5 days . To d e t e rm i n e  whe t h e r  o r  not t h e  pro ­
t e c t ive e f fe c t  w a s  a r e s ul t o f  the t ran s fe r  o f  r e s i dual 
pyran r a t h e r  t han p e r i t o n e a l  c e l l s , two g roup s o f  s uck l i n g  
m i c e  r e c e ived e i t h e r  pyran o r  g l y c o g en a l one . Trea tment o f  
n e o n a t a l  m i c e  w i t h  t h e  c omp oun d s  a l one a t  the d o s e s  ind i ­
c a t e d  gave no s i gn i f i c ant p r o t e c t i ve e f f e c t . 
TABL E  6 
P r o t e c t i on A g a i n s t  HSV - 2  I n f e c t i o n  in  Suc k l i n g  M i c e  by 
T r a n s f e r  o f  P e r i t one a l  Exuda t e  C e l l s  
T r e a tment a I n f ec t i o n  w i t h  HSV Numb e r  D e a d / To t a l  Numb e r  D e a d / To t a l  
Exp . 1 Exp . 2 Exp . 3 
None + ND 4 / 1 0  7 / 1 1  1 1 / 2 1  ( 5 2  % )  
No rma l PEC  + 8 / 1 1  8 / 1 8  1 1 / 1 5  2 7 / 4 4  ( 5 1 %  ) 
Pyran PEC  + 3/ 1 0  1 / 2 1  3/ 1 1  7 / 4 2  ( 1 7 % ) c 
G l yc o g e n  PEC  + 3 / 1 1  5 / 1 2  7 / 1 6  1 5 / 3 9  ( 3 8 % ) d 
Pyran b + ND 6 / 1 8  9 / 1 4  1 5 / 3 2  ( 4 7 % )  
G l yc o g enb + ND 3/ 8 5 / 1 0  8 / 1 8  ( 4 4  % )  
ap e r i t o n e a l  c e l l s  we r e  r emove d from adu l t  BAL B / C  m i c e  inocul a t e d  i n t r ap e r i tone a l l y  
w i t h  e i t h e r  pyran ( 2 5  mg/ kg ) o n  day 1 ,  g . 5  ml o f  2 . 5 % o n  day 5 ,  o r  n o t h i n g . The 
c e l l s  were harve s t e d , wa s h e d  and 3 x 1 0  c e l l s  in  0 . 2 ml were inocul a t e d  int rap e r i ­
tone a l l y  i n t o  4 - 8  day o l d  s u c k l ing m i c e . The s u c k l ing m i c e  were inocu l a t e d  i n t r a ­
pe r i t one a l l y  w i t h  HSV - 2  2 4  hour s l a t e r . 
b Suc k l ing  m i c e  t r e a t e d  d i re ct ly w i t h  immunomo du l a t o r s  on the s ame do s e  and s c hedul e .  
c p < . 0 2  a s  comp a r e d  to  s uc k l ing  m i c e  r ec e i v i n g  no rma l P E C  o r  n o t h i n g . 
d N . S .  
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K in e t i c s  o f  t he ant i v i r a l  a c t i v i ty o f  pe r i toneal  exu ­
d a t e  c e l l s  from m i c e  i n f e c t e d  w i t h  HSV - 2 .  The p r e v i o u s  
e xp e r imen t s  d e mo n s t r a t e d  that  ma c r o p hag e s w e r e  invo l v e d  
in  re s i s t an c e  t o  sy s t em i c  HSV i n fe c t i on , a s  e v i denc e d  b y  
dec r e a s e d  r e s i s t an c e  on  inh i b i t i o n  o f  macrophage  func t i on 
and inc r e a s e d  r e s i s t an c e  on t ran s f e r  of ac t i vat e d  mac r o ­
p ha ge s .  The fo l l owing e x p e r imen t s  were  d e s i gn e d  t o  e s t a b ­
l i s h  d i re c t l y  t h a t  macropha g e s  w i t h  ant i v i r a l  act i v i t y  
app e a r e d  dur in g  s y s t em i c  HSV i n f ec t i on . A s e r i e s  o f  k inet i c  
exp e r imen t s  e s t a b l i s h e d  t h e  app e a rance o f  t h e  ant i v i ra l  ac ­
t iv i ty o f  p e r i t on e a l  c e l l s .  M i c e  we r e  i n f e c t e d  i . p .  on 
day - 7  and d a y s  - 4  through - 1  w i th a d o s e  o f  v i ru s  caus i n g  
5 0  t o  7 0 %  mo r t a l i ty (Ta b l e  7 ) . O n  day 0 ,  p e r i t o n e a l  c e l l s  
we r e  h a r ve s t e d  and a s s ay e d  f o r  ant i v i ra l  ac t i v i ty . Y i e l d s 
o f  p e r i t on e a l  c e l l s  a s  we l l  a s  p e r c e n t  monocyt e s  a s  de t e r ­
m i n e d  u s i n g  Wr i ght ' s  s t a in w e r e  d e t e rm i n e d  a t  the d i fferent 
t ime p e r i o d s . The r e  wa s a s l i ght inc r e a s e  ( a p p ro x .  2 - fo l d )  
i n  t h e  numb e r  o f  p e r i tone a l  c e l l s  harve s t e d  a t  days 1 - 4  
a f t e r  i n f e c t i o n  a s  we l l  a s  a s l i ght inc r e a s e  in  the numb e r  
o f  c e l l s  o f  t h e  mono cyt i c  s e r i e s . 
I n  m i c e  in f e c t e d  on day - 1 , t h e r e  w a s  an inc r e a s e  in 
t he numb e r  of HSV PFU o v e r  and above the cont ro l va l ue s . 
Th i s  wa s p r o b a b l y  a t t r i b ut ab l e  t o  the p r e s en c e  o f  r e s i dua l 
v i ru s  in  t h e  p e r i tone a l  c av i t y , wh i c h  wa s s ub s e quen t l y  
t ra n s f e r r e d  t o  t h e  c u l t ur e . The r e  w a s  l i t t l e  o r  n o  chang e 
n o t e d  i n  t h e  v i ru s  y i e l d  from s u p e rnat ant f l u i d s  a s  comp a r e d  
PEC Add e d  
( Da y s  A ft e r  H SV - 2 )  
None 





TABL E  7 
T im e  C o u r s e  A f t e r  I P  HSV - 2  I n f e c t i o n  o f  
Ant i v i r a l  Ac t iv i t y  o f  P e r i t on e a l  C e l l s  ( P E C )  
P E C  C h a r ac t e r i s t i c s  
No . 7Mo g s e  P e r c en t  b ( x  1 0  ) Mo nocyt e s  
2 . 6  2 7  
5 . 0 3 4  
4 . 9  3 6  
4 . 3  3 8  
3 . 6  3 3  
An t i v i ra l  
HSV':L p a q u e s 
( P FU - S E )  
3 7 . 4 ! 0 . 7 
3 1 . 2 ! 2 . 3  
5 8 . 3 ! 3 . 2 
2 2 . 3  ! 2 . 1  
5 . 5 ! 1 . 4  
1 5 . 8  ! 1 . 9  
Ac t i v i tya 
HSV - 2 Yie ld 
( l o g l O PFU/ml ) 
5 . 8  
5 . 7  
5 . 6  
5 . 5  
< 3 . 0 
3 . 7 
aVero  c e l l s  we r e  i n f e c t e d  w i t h  HSV - 2  and 3 x 1 0 6 no rma l PEe  o r  P E C  from HSV - 2 
in fec t e d  m i c e  a d s o r b e d , nonadhe rent  c e l l s  r emoved w i t h was h i n g , and v i rus y i e l d s 
and P F U  we r e  d e t e rm i ne d  a t  3 days . 
bD i ffe rent i a l  count , Wr i ght ' s  s t a in . 
VI 
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t o  c u l t u r e s w i thout P E C . C u l t ur e s  o f  HSV i n f e c t e d  Vero  
c e l l s  and P E C  from mice  i n f e c t e d  2 days p r e v i ous l y  s howe d 
s ome a c t i v i t y , w i t h  a 4 1 %  r educ t i on i n  the numb e r  o f  HSV PFU 
and a 2 - fo l d  r e duc t i o n  i n  HSV - 2 y i e l d .  Cul t u r e s  wi th PEC  
from mice  i n f e c t e d  3 days p r e v i ou s l y  d emon s t ra t e d  t h e  op ­
t im a l  p e r i o d  f o r  ant i v i ra l  ac t iv i ty . The re  wa s an 8 6 %  
r e duc t i o n  i n  t h e  numb e r  o f  v i ru s  p l aque s a s  we l l  a s  a 
g r e a t e r  t han 2 . 8  l o g l O r e duc t i o n  i n  y i e l d  o f  v i rus . P E C  
from m i c e  i n f e c t e d  4 d a y s  p r e v i ou s l y  a l s o showed s i gn i f i cant 
a n t i v i r a l  a c t i v i t y  with a 5 8 %  r e duc t i o n  of  HSV PFU and a 2 . 1  
l o g l O r e duc t i o n  i n  v i ru s  y i e l d .  By day 7 a f t e r  HSV i n fec ­
t io n , howeve r ,  t he PEC  r e s p on s e  had wan e d  and approached 
a c t i v i t y  s im i l a r  t o  that  n o t e d  w i t h no rma l un t re a t e d  p e r i ­
t o n e a l  c e l l s .  
Ant i v i r a l  a c t i v i t y  i n  v i t ro o f  nonadh e r en t  and adherent  
pe r i t o n e a l  exud a t e  c e l l s  f r om HSV i n f ec t e d  m i c e . The s e  e x ­
p e r imen t s  we r e  d e s i gn e d  t o  charact e r i z e  t h e  c e l l ( s )  r e s p o n ­
s ib l e  fo r t h e  an t i v i r a l  a c t i v i ty on t h e  ba s i s  o f  adh e r e n c e  
p ro p e r t i e s . V e r o  c e l l s  we re  i n f e c t e d  a s  d e s c r i b e d  i n  
Ma t e r i a l  and Me t h o d s  a n d  o v e r l a i d w i t h p e r i t o n e a l  exuda t e  
c e l l s  from n o rm a l  o r  HSV - 2  i n f e c t e d  m i c e  ( 3  days a f t e r  
i n fe c t i on ) . P e r i t on e a l  c e l l s  w e r e  a l l owed t o  adhere  on t h e  
i n f e c t e d  t a r g e t  c e l l c u l t u r e s  f o r  2 hour s . A f t e r  2 hour s , 
nonadhe r e n t  c e l l s  w e r e  r emove d , wa s he d , adj u s t e d  t o  t h e  
app rop r i a t e  c e l l  c o n c e n t r a t i o n  and incub a t e d  w i t h o t h e r  i n ­
f e c t e d  c e l l  c u l t u r e s .  C u l t ur e s  cont a in in g  adh e r e n t  e f fec ­
t o r  c e l l s  we r e  wa s h e d  v i go r o u s l y  to  r emove any r e s i du a l  
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nona d h e r e n t  c e l l s  and p r ep a r e d  a s  de s c r i be d .  App r o x i ma t e l y  
2 8 - 3 0 %  o f  t h e  p e r i t o n e a l  c e l l s  we r e  adh e r en t . 
Nonadh e r e n t  c e l l s  from e i t h e r  no rma l o r  HSV - i n f e c t e d  
m i c e  p r o v i d e d  no r e duc t i o n  i n  v i ru s  p l a que format ion o r  i n  
t he v i ru s  y i e l d  i n  s up e rnatant f l u i d s  (Tab l e  8 ) . No rma l ad ­
h e re n t  c e l l s  p r o v i d e d  s ome r e duc t i on i n  p l aque forma t i o n  and 
to a l e s s e r  d e g r e e  in v i rus  y i e l d  i n  s u p e rn a t ant  f l u i d s . 
Adhe r e n t  c e l l s  from m i c e  i n f e c t e d  w i t h  H SV showed a s i gn i ­
f i c an t  r e duc t i o n  i n  t he numbe r o f  v i rus  p l aq u e s  a s  we l l  a s  a 
2 . 2  l o g l O r e duc t i o n  i n  v i r u s  i n  the  supernatant  f l u i d s , 
s ug g e s t i n g  t h a t  t h e  popu l a t i o n  o f  c e l l s  r e s p on s i b l e  fo r t he 
an t iv i r a l  a c t i v i t y  r e s i d e d  i n  t h e  adhe rent fract i o n  wh i c h  
c o n t a in e d  a t  l e a s t  7 2 %  e s t e r a s e  po s i t ive c e l l s . 
L a c k  o f  spe c i e s  spe c i f i c i ty o f  an t i v i r a l  act i v i ty o f  
pe r i t o n e a l  c e l l s  from m i c e  i n f e c t e d  w i t h  HSV - 2 .  To de t e r ­
m i n e  whe t h e r  o r  n o t  a s yn g en e i c  s y s t em be tween e f f e c t o r  and 
v i r u s  i n f e c t e d  t a r g e t  c e l l  woul d p roduce g r e a t e r  ant i v i r a l  
ac t iv i ty , t he syngen e i c  mou s e  emb ryo f i b r o b l a s t  c e l l  and the  
xeno g en e i c  Ve ro  c e l l  l in e  we r e  i n f e c t e d  with HSV - 2 .  P e r i ­
t on e a l  exud a t e  c e l l s  from i n f e c t e d  m i c e  i nh i b i t e d  v i ra l  
g rowth i n  bo t h  mo u s e  embryo f i bro b l a s t s  and Vero  c e l l s  
( Ta b l e  9 ) . Th e r e  wa s a t  l e a s t  a l a - fo l d  r e d uc t i o n  ( 1 . 6  and 
2 . 1  l o g l O ) i n  v i r a l  t i t e r s  of s up e rn a t ant  f l u i d s  from Vero 
and mou s e  embryo c u l t u r e s . I n  t h i s  e xp e r iment , no rma l c e l l s  
p r o v i ded some r e duc t i o n  i n  v i r a l  y i e l d s , but no t to the 
d e g r e e  as d i d  c e l l s  from i n f e c t e d  m i c e . 
TAB L E  8 
Ant i v i r a l  Ac t i v i t y  o f  Adh e r e n t  o r  Nonadhe rent  Pe r i t o n e a l  C e l l s  
F r o m  No rma l M i c e  o r  M i c e  I n f e c t e d  w i t h  HSV - 2  
I nh i b i t i on o f  HSV - 2 a 
% E s t e r a s e  
T r e a tment C e l l s  Po s i t ive  
No ne 
Normal  Adh e r e n t  6 8  
No rma l Nonadhe rent 1 
HSV - 2  Adhe rent  7 2  
HSV - 2 Nonadhe rent 2 
Pl aque F� rma t i o n  
( P FU - S E )  
4 9 . 0  � 1 . 1  
2 8 . 3  � 0 . 9  
+ b 4 9 . 0  - 4 . 0  
0 . 2  � 0 . 2 c 
+ b 4 8 . 0  - 2 . 0  
Vi rus  Yie ld 
( l o g l O PFU/ml ) 
5 . 8  
5 . 0  
> 5 . 0  
3 . 6 
5 . 6  
a 3 x 1 0 6 p e r i t on e a l  c e l l s  w e r e  a d s o r b e d  t o  HSV - 2 i n f e c t e d  Vero  c e l l s  f o r  2 hr . The 
r e s i d u a l  nonadhe rent c e l l s  we r e  r ecove r e d  and incub a t e d  w i t h  dup l i c a t e  HSV - 2 infe c t e d  
Ve ro  c e l l s . T h e  y i e l d s  o f  v i rus  and P F U  we r e  d e t e rmined 3 days l a t e r . App r o x ima t e l y  
2 8 - 3 0 %  o f  t he t o t a l  p e r i t one a l  c e l l  popu l a t i o n  adhe r e d  w i t h in 2 hr . 
bN . S .  
c p < . 0 5 a s  c omp a r e d  t o  c o nt r o l  and no rma l PEC . 
0\ 
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TAB L E  9 
Lack o f  S p e c i e s  S p e c i f i c i t y  o f  Ant i v i r a l  Ac t i v i t y  o f  
. a P e r i t on e a l  C e l l s  
Add e d  
None 
No rma l 
HSV - 2 
P e r i t one a l  C e l l s  from HSV - 2 I n f e c t e d  M i c e  
Y i e l d o f  HSV - 2  I n  
Ve ro  C e l l s  
Yie ld -Reduc tion 
( l o g l O PFu/ m l ) ( l o g l O ) 
5 . 4  
5 . 0  0 . 4  
3 . 8  1 . 6  
Mo u s e  Emb ryo C e l l s  
Yield Reduct-ion 
( l o g l O P FU/ m l )  ( l o g l O ) 
4 . 3  
3 . 2 1 . 1  
2 . 2  2 . 1  
a 3 x 1 0 6 p e r i t o n e a l  c e l l s  w e r e  a d s o r b e d  to  HSV - 2 i n f e c t e d  Ve ro o r  s econdary mo u s e  
emb ryo f i bro b l a s t s  f o r  2 hr , t h e  nonadh e r ent c e l l s  r emo ved w i t h w a s h i n g , and v i rus 
y i e l d  a s s a yed 3 days l a t e r . 
0\ 
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N o n spe c i f i c i ty o f  ant i v i r a l  ac t iv i ty o f  adhe rent  
pe r i t o n e a l  e xuda t e  c e l l s . I t  was  o f  i n t e r e s t  t o  det e r m i n e  
whe t h e r  t h e  an t i v i r a l  ac t iv i t y  o f  p e r i t o n e a l  exud a t e  c e l l s  
harve s t e d  f r o m  HSV - i n f e c t e d  m i c e  was  s p e c i f i c  fo r HSV . 
Th e r e fo r e , t h e  a n t i v i ra l ac t i v i t y  o f  t he s e  c e l l s  wa s t e s t e d  
a g a i n s t  c e l l s  i n fe c t e d  w i t h  HSV - 2  o r  an  unre l a t e d  s in g l e ­
s t randed RNA v i ru s , ve s i cu l a r  s t omat i t i s  v i rus  (Tab l e  1 0 ) . 
I t  wa s o b s e rv e d  t h a t  c e l l s  from HSV - 2 i n fe c t e d m i c e  we r e  
c ap a b l e  o f  i nh i b i t i n g  HSV - 2  and VSV g rowth a s  m e a s u r e d  by 
PFU a s  we l l  as r e duc i n g  v i r a l  t i t e r s  i n  s up e rn a t ant f l u i d s . 
TABLE 1 0  
Nonspecificity of Antiviral Activity of Peritoneal Cells 
From HSV-2 Infected Mice 
Inhibition of Virus in Target Cells I nfected Witha 
HSV-2 VSV 
Per i toneal Ce 1 1  Plaq1fes Virus Yield Plaq1fes Virus Yield 
Source (PFU - SE) (loglOPFU/ml) (PFU - SE) (loglOPFU/ml) 
None 48. 5 -: 1 . 1 4. 0 32.5 -: 1.1 6. 0 
Normal 3 6 . 3 -: 3 . 3 4. 2 20.1 -: 3 . 3 6 . 0  
HSV-2 0 3. 0 0. 2 -: 0. 2 4.8 
aVero cells �nfected with either HSV-2 or vesicular stomatitis virus were overlaid 
with 3 x 10 peritoneal cells for 2 hr, the nonadherent cells removed with washing, 
and plaques or virus yields determined 3 days later. 
--- . - "" . ;6 
0-
U1 
6 6  
D I SCUS S I ON 
B a s e d  on o b s e rvat i o n s  o f  the inc r e a s e d  s e ve r i t y  o f  HSV 
in  pat i en t s  d e f i c i e n t  in  c e l l ul a r  immun i t y  as we l l  as in 
an i ma l  mod e l s , i t  has b e en s hown that c e l l - me d i a t ed immu ­
n i t y ( CM I ) i s  an imp o r t ant d e f en s e  me chan i s m .  Enn i s  ( 1 9 7 3 )  
d e mo n s t ra t e d  tha t  s yn g en e i c  i mmun e s p l e en c e l l s  p a s s i ve l y  
t ran s fe r r e d  i n t o  no rma l m i c e  mar k e d l y  p r o t e c t e d t hem from a 
l e t h a l  c ha l l en g e  w i t h HSV . Bl anden r e p o r t e d  s i m i l a r  r e s u l t s  
u s i n g  a s im i l a r mod e l  I n  t h e  mo us epox s y s t em , w i t h  dec r e a s e d  
t i t e r s o f  mou s epox v i ru s  in  the l i ve r s  o f  m i c e  r e c e i v i n g  
immune s p l e e n  c e l l s  ( B l anden e t  a l . ,  1 9 7 1 ) . 
The de l a yed t ype hyp e r s ens i t i v i t y  ( DTH ) r e p r e s en t s  one 
o f  the e a r l i e s t  immuno l o g i c  s y s t ems as d e s c r i b e d  by Jenn e r  
in  1 8 0 1 . The p r o t o type fo r t h e  d e l ayed hype r s en s i t i v i t y  
r e a c t i o n  i s  c r e d i t e d  to  Ko c h  who d e s c r i b e d  a cutaneous 
r e ac t i on o b s e rved when guinea p i g s , prev ious l y  expo s e d  to 
t ub e r c u l o s i s , we r e  i n j e c t e d  with a f i l t r a t e  o f  the bac i l l i .  
Ano t h e r  d i s t i n gu i s h ing f e a t u r e  o f  the DTH r e s p o n s e  i s  i t s  
ab i l i t y  t o  b e  t r an s fe r r e d  i n t o  DTH (Da v i d , 1 9 7 5 )  anima l s  
u s i n g  l ymp h node s , s p l een o r  p e r i t on e a l  exudat e s  from DTH 
p o s i t ive  an i m a l s .  P e a k  s ens i t i v i t y  o c c u r s  2 4  hours fol ­
l ow i n g  i n fe c t i on w i t h  t h e  s p e c i f i c  ant i g en i n t o  a s e n s i t i z e d  
ho s t  a n d  wan e s  by  4 8  hour s . 
Seve r a l  a s p e c t s  o f  c e l l - m e d i a t e d  immun i t y  have been 
demo n s t r a t e d  f o l l owing i n f e c t i on w i t h  HSV - 2 .  Mo rahan et  
a l . ( 1 9 7 7 )  showed an inc r e a s e  in in  v i t ro b l a s t o g ene s i s  
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s p e c i f i c  f o r  H SV - 2 an t i g ens  in m i c e  p r e v i ou s l y  infec t e d  
w i t h  the  v i ru s . Syngene i c  s p l e en c e l l s  f r o m  HSV - i mmune 
m i c e  con f e r  p r o t e c t i o n  when p a s s ive l y  t ra n s f e r r e d  into 
n a ive m i c e . C o r r e s ponding l y , d e p l e t ion o f  T - c e l l s  in v i vo 
r e s u l t s  i n  an i nc r e a s e d  r e s i s tanc e  to  the infec t i on (Mo rahan 
and Mc C o r d , 1 9 7 5 ) . 
The de l ay e d  type hype r s en s i t iv i t y  r e s po n s e  to  HSV - 2  
h a s  not  b e e n  p r e v i o u s l y  repo r t e d  in the mou s e  mo de l . Thu s , 
i t  wa s o f  i nt e r e s t  t o  d e s i gn a mo de l fo r d e t e rmining the 
k in e t i c  p a t t e rn s  o f  the DTH r e s p o n s e  to  HSV , and at t emp t to  
c o r r e l at e  p a t t e r n s  of  DTH r e s pons iven e s s  to  o ther  a s p e c t s  
o f  c e l l - me d i a t ed immun i t y  wh i c h  have b e en p re v i ou s l y  re -
p o r t e d . U s i n g  t he i s o t o p i c  foo t p a d  a s s ay r e p o r t e d  by 
P a r a j npe and c o - wo r ke r s  ( 1 9 7 2 ) , a mo d e l  was e s t ab l i s hed 
wh i c h  demon s t ra t e d s o me i nt e r e s t ing p a t t e rn s  re l a t ing to 
the route o f  i n f ec t ion . 
The DTH r e s p o n s e  t o  the  HSV - 2  ant i g en was found to  be 
maximal  a t  24 hour s fo l l ow i n g  an t i gen cha l l en g e  in m i c e  
p r e v i ou s l y  i n f e c t e d  w i t h  HSV - 2 .  T h e  r e spon s e  was a l s o s p e ­
c i f i c  to  HSV - 2  ant i gen . A r e spon s e  wa s not  de t e c t ab l e  ear ­
l i e r  t han 6 days fo l l owing int r avenous infec t i on and p e r ­
s i s t e d  unt i l  app r o x i ma t e l y  4 0  days a f t e r  infec t ion in the 
s ur v i v i n g  m i c e . Th e r e  wa s no apparent c o r r e l a t ion wi th 
s ur v i va l , howeve r , as e v i denced by the fac t that an equal 
p r o p o r t i o n  o f  DTH n e ga t ive and DTH p o s i t ive mice survived 
the i n i t i a l  in fec t i o n .  Th i s  may have b e en due t o  the fact 
that t ho s e  m i c e  wh i c h  we r e  p r e sumed t o  be DTH n e g a t i ve we re 
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not  i n i t i a l l y  in fec t e d  w i t h  a d o s e  o f  v i rus  s u f f i c i ent t o  
e l i c i t  a DTH r e s pon s e  o r  caus e a l e t h a l  infec t i on . I t  
wou l d  b e  o f  i n t e r e s t  t o  de t e rm ine i f  the  p r e s en c e  o f  a DTH 
r e spon s e  in m i c e  h a s  any c o r r e l at ion to the  e s t ab l i shment 
o f  l at ency in  t he h o s t . 
The DTH r e s p o n s e  was found t o  a l s o be  p r e s ent in  m i c e  
i n f e c t e d  vag i na l l y .  The s e  d a t a  sug g e s t  that s ome s y s t em i c  
s en s i t i z a t i on o c c u r r e d , a l t hough p r ev i o u s  o b s e rva t i ons have 
r e p o r t e d  t h a t  the v i r u s  r ep l i c a t e s  l o ca l l y in the vag i n a l  
a r e a , p r o c e e d s  d i r e c t l y  t o  t h e  s p i n a l  c o r d , a n d  ul t ima t e l y  
t o  t h e  c en t r a l  n e rvous s y s t em ( B r e in i g  e t  a l . ,  1 9 7 8 ) . The 
l ymp h no d e s  p r o x imal  to  the vag i n a l  a r e a  and dr a in in g  the 
a r e a  of t he f o o t p a d  may be  s i m i l a r and , t hu s , be  r e s p o n ­
s i b l e  fo r t h e  s en s i t i z a t ion and the  p r e s en c e  o f  t h e  DTH 
r e spon s e  in t he f o o t p ad . Howeve r , we have a l s o s hown that 
s p l e en c e l l s  from vag ina l l y i n f e c t e d  mice are  s en s i t i z e d  to 
the HSV ant i g en as ev i d enc e d  by b l a s t o g e ne s i s  ( B r i en i g  et 
a I . , 1 9 7 8 ) . 
A po int  i n  cont r a s t  w i t h  t he DTH r e spon s e  in v a g i na l l y  
and s y s t e m i c a l l y  i n f e c t e d  anima l s  wa s t h e  fact that the DTH 
r e s p on s e  in vag i na l l y  i n fe c t e d  m i c e  r e p r e s en t e d  a mo re  
t rans i ent p h enomenon a s  c omp ar e d  to  s y s t e m i c a l l y  infec t e d  
an ima l s .  Whe r e a s  t h e  D T H  r e spon s e  wa s ma i n t a ined beyond 4 0  
d a y s  a f t e r  i n fe c t i on in int raveno u s l y  infec t e d  m i c e , vag i ­
n a l l y  i n f e c t e d  m i c e  e l i c i t e d  a re spon s e  wh i c h  had wane d  by 
2 1  days a ft e r  i n f e c t i on . A p o s s i b l e  exp l ana t i on for the  
de f i c i enc i e s  in  t he l on g ev i t y  of  t he re spon s e s  may be  due 
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t o  t h e  d e g r e e  o f  s en s i t i z a t i o n .  Sy s t em i c  i n fe c t i on a s  
o b s e rv e d  through p a t h o g en e s i s s tud i e s  h a s  b e en found in  
v i s c e ra l  a s  we l l  a s  r e t i c u l o endoth e l i a l  o r g an s , p r i o r  to  
e n t r y  i n t o  t h e  c en t r a l  n e rvous s y s t em . 
S p e c i f i c  immune r e spo n s e s  p l ay a c r i t i c a l  ro l e  in  
r e s i s t anc e t o  a var i e ty of  v i r a l  i n f ec t i on s . Mo r e o ve r , 
s p e c i f i c  r e sp on s e s  s e rve a s  t h e  m a i n  d e f e n s e  mechan i sms 
a g a i n s t  r e - i n f e c t i on . Fo l l o w i n g  p r imary infec t i on ,  howeve r , 
n o n s p e c i f i c  h o s t  d e fe n s e  mechan i s m s  p l ay a c r i t i c a l  ro l e , 
p r i o r  t o  t h e  a c qu i s i t i on o f  s p e c i f i c  i mmune r e s p on s e s . 
The s e  n o n s p e c i f i c  d e fen s e s  c o n s i s t  o f  a va r i et y  o f  p r e ­
e x i s t i n g  f a c t o r s  inc l u d i n g  b a r r i e r s  p r event i n g  v i r u s  pene ­
t ra t i on , non s p e c i f i c  ant i v i r a l  fac t o r s  and c e l l s  capab l e  o f  
non s p e c i f i c  ant i v i r a l  a c t i v i t y  (Mo g en s e n , 1 9 7 9 ) . 
The r e  have b e e n  s ev e r a l  l in e s  o f  e v i dence wh i ch s u g g e s t  
t h a t  mac r o ph a g e s  a r e  imp o r tant e f fect o r  c e l l s  i n  re s i s t ance 
to HSV i n f e c t i on s  as we l l  as t o  a var i e t y  of other v i r a l  
i n f e c t i o n s  ( H i r s c h  e t  a l . ,  1 9 7 0 ) . John s o n  ( 1 9 6 4 ) , us ing  
immuno f l uo r e s c en c e  t e c hn i que s , d emon s t r a t e d  that young mice  
we r e  mo r e  h i gh l y  s u s c ep t i b l e  t o  HSV i n f ec t i on b e c a u s e  of  
t h e  l ac k  of  a popul a t ion of  ma ture  mac rophage s .  Mo g en s en 
( 1 9 7 8 )  a l s o r epo r t e d  t h a t  mac ropha g e - r e l a t e d  a g e - dep enden t 
r e s i s t an c e  p l ays  a ro l e  in  p r o t e c t ing  BAL B/c m i c e  from 
i n t r ap e r i t o n e a l  HSV - 2  i n duc e d  foc a l  n e c ro t i c  hepa t i t i s . 
St e ven s and C o o k  ( 1 9 7 1 )  u s ing  a b i ochem i c a l  app roach ex ­
t en d e d  the s e  o b s e rvat i o n s  t o  t h e  f in d i n g  that  mac rophage s 
i n fe c t e d  w i t h  HSV und e r go an abo r t i ve infec t i on due t o  
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imp r o p e r  v i r a l  a s s e mb l y . Mo reove r , H i r s c h  e t  a l . ( 1 9 7 0 )  
demo n s t r a t e d  i n  v ivo t h a t  r e s i s t ance t o  HSV i n fec t i o n  i n  
a du l t  m i c e  c o u l d  b e  a b r o g a t e d  by p re t r e atment o f  m i c e  w i t h  
s i l i c a , an a g ent  kn own to  b e  t o x i c  fo r mac ropha g e s . Ot h e r s  
have s hown t h a t  i n n a t e  r e s i s t an c e  c a n  b e  enhanced b y  t r eat ­
ment o f  m i c e  w i t h  a g ent s  wh i c h  mo dul a t e  o r  p o t e n t i a t e  
mac rophage  fun c t i on ( S t a r r  e t  a l . ,  1 9 7 6 ; Mo rahan et al . ,  
1 9 7 4 ) . Adu l t , a c t i va t e d mac r o p h a g e s  when pa s s i ve l y  t r an s ­
f e r r e d  i n t o  n e o na t a l  m i c e  mar ke d l y  p r o t e c t e d  m i c e  from HSV 
l e t h a l i t y  ( Br e i n i g  e t  a l . ,  1 9 7 8 ) . F rank and c o - wo r ke r s  
( 1 9 7 8 )  demon s t ra t e d  t ha t  HSV v i rus  mul t ip l i c a t i on in mac r o -
p h a g e s  d i f f e r e d  marke d l y  i n  s u s c e p t i b l e  o r  r e s i s t ant  s t r a i n s . 
Mac ropha g e s  from h i gh l y  s u s c e p t i b l e  NMRI s t ra i n s  s up p o r t e d  
r e p l i c a t i on o f  H S V  1 a n d  2 t o  a muc h g r e a t e r  d e g r e e  t han 
d i d  mac ropha g e s  from h i gh l y  r e s i s t an t  C 5 7 / B l  m i c e . The s e  
r e s u l t s  e x t en d  t he o r i g in a l  o b s e rvat i o n s  o f  Lo p e z  ( 1 9 7 5 )  
who r e p o r t e d  t h a t  s u s c e p t i b i l i t y  va r i e d  d ramat i c a l l y  among 
d i fferent  i n b r e d  s t ra in s  of m i c e . 
Our r e s u l t s  a r e  c on c o r dant w i t h  t ho s e  r e p o r t e d  by 
H i r s c h  e t  a l . ( 1 9 7 0 )  c o n c e rn i n g  the e f fec t s  of s i l i c a  on 
d e p r e s s in g  r e s i s t an c e  to i n t r a p e r i t o n e a l  HSV i n fe c t i o n  as  
we l l  as  with  other  v i ru s e s . We n o t e d  a s i gn i f i c ant i nc r ea s e  
i n  s u s c ep t i b i l i t y  when m i c e  t r e a t e d  i n t r ap e r i t onea l l y  wi th 
s i l i c a  we r e  s u b s e quen t l y  i n f e c t e d  by t h e  i n t r avenou s route . 
Th i s  wa s i n  c o n t r a s t  t o  H i r s c h  e t  a l . ( 1 9 7 0 )  who adm in i s t e r e d  
t h e  s i l i c a  a n d  v i ru s  by t h e  i nt rape r i t on e a l  rout e . 
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I n  add i t i on t o  t he u s e  o f  s i l i c a  o n  s u s c ep t i b i l i t y  t o  
s y s t em i c  i n f e c t i o n , t wo o t h e r  mac rophage inh i b i t o ry agent s 
not  p r ev i ou s l y  repo r t e d  t o  have b e e n  u s e d  in  the HSV s y s t em 
we r e  ut i l i z ed for t h e  b a s i s  o f  comp a r i s on o f  the e ff i c a cy 
o f  t h e  t h r e e  agent s .  Dext ran s u l fa t e  (MW 5 0 0 , 0 0 0 )  h a s  b e en 
s hown t o  i nc r e a s e  s u s c e p t i b i l i t y  to  L i s t e r i a in fect ion in  
mice  ( Hahn , 1 9 7 4 ) . Trypan b l ue h a s  b e e n  shown to  d e c r e a s e  
r e s i s t an c e  o f  m i c e  t o  t umo r a l l o g raft  cha l l en g e  i n  m i c e  in  
a d d i t i o n  t o  a b r o g a t ing t h e  p r o t e c t ive  e f fect  of  p a s s ive 
t ra n s f e r  of t umo r immun i t y  ( H i b b s , 1 9 7 4 ) . As o b s e rved in 
the r e s u l t s , a l l  t h r e e  a g e n t s  inc r e a s e d  s u s c ep t i b i l i t y o f  
m i c e  t o  s y s t em i c  HSV i n fe c t i on . 
S i l i c a  h a s  b e e n  s hown t o  d ec r e a s e  re s i s t ance to  a num ­
b e r  o f  v i r a l  a gent s inc l u d ing HSV - l ,  HSV - 2 ,  y e l l o w  fever 
v i ru s  and C o x s ac k i e  v i r u s , a s  we l l  as  enhanc ing carc ino g en ­
i n du c e d  t umo r g rowth ( Z i sman e t  a l . ,  1 9 6 9 ;  Ke l l e r , 1 9 7 6 ) . 
The mechan i sm o f  a c t i on app e a r s  t o  be  auto l y s i s  o f  the 
macropha ge . D e x t ran s u l fa t e  app e a r s  to  exert its  i n h i b i ­
t o ry e ff e c t  n o t  b y  k i l l ing  t h e  c e l l but by inh i b i t in g  
p h a g o somal - l y s o s om a l  fu s i on ( Hahn a n d  B i e r t he r , 1 9 7 4 ) . 
F r ank e t  a l . ( 1 9 7 8 )  r e p o r t e d  r e c ent l y  that t h e  e f fe c t  o f  
d e x t ran s u l fa t e  on HSV i n f e c t i on wa s o n l y  e v i dent over  a 
s ho r t  p e r i o d  o f  t ime and c o n c l u d e d  that  d e c r e a s e d  re s i s ­
t an c e  by t h i s  a g ent mu s t  be  a f fe c t in g  an e a r l y  s t a g e  o f  
v i r u s  ho s t  i n t e r a c t i on . Trypan b l ue a l s o app e a r s  to  me d i a t e  
i t s  act i v i t y  t h r o u gh i nh i b i t ion o f  l y s o soma l  fun c t i on .  
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F u r t he rmo r e , i t  was o f  int e r e s t  to  d e t e rmine i f  route 
of  i n f e c t i o n  had any e f fe c t  on  whe t h e r  or  not the s e  t h r e e  
mac r o p h a g e  inh i b i t o r y  agent s wo u l d  inc r e a s e  s u s c e p t i b i l i t y . 
The r e fo r e , we admi n i s t e r e d  t he s ame drug r e g imen s a s  w i t h  
s y s t e m i c  HSV , but i n f e c t e d  m i c e  by t h e  va g i na l rout e . The 
l e t ha l i t y  a s  a r e s u l t  o f  va g i n a l  infect i o n  wa s not ma rke d l y  
a ff e c t e d  a s  e v i de n c e d  by v i r t ua l l y  no d i ffe r enc e s  in t h e  
L D S O  o r  l o c a l  v i rus  r e p l i c a t i on i n  t h e  va g in a l  a r e a . 
S e ve r a l  p o s s i b i l i t i e s  m i ght e xp l a in t h i s  l a c k  o f  e f fe c t . 
The mac r o p h a g e  inh i b i t o ry d r u g s  we r e  admin i s t e r e d  by the 
i nt r ap e r i t on e a l  rout e and , t hu s , may p r ima r i l y a ffect  
mac ro p ha g e s  in  t h e  p e r i t on e a l  cav i t y  and p r o x ima l re t i cu ­
l o endo t he l i a l  s y s t e m  ( R E S )  o r gans  such a s  the l iv e r  or  
s p l e e n . The s e  o r gans  may b e  invo l v e d  in  con t ro l l ing  t h e  
s p r e ad fo l l ow i n g  s y s t em i c  i n fe c t i on , but not  in  va g in a l  
i n f e c t i o n , i n  wh i c h  v i rus  h a s  b e e n  s hown t o  rep l i c a t e  
l o c a l l y  a n d  p r o c e e d  d i r e c t l y  i n t o  t h e  cent r a l  ne rvous 
s y s t em (Mor ahan et a l . ,  1 9 7 7 ) . A s econd p o s s i b i l i t y  t o  be  
c on s i d e r e d  is  that , a s suming that  mac ropha g e s  a r e  impo r ­
t an t , t h e y  r e s i d e  i n  t h e  va g ina l a r e a  and w e r e  not mar k e d l y  
a f f e c t e d  b y  i n t r a p e r i t o n e a l  adm in i s t r a t i o n  o f  the mac r o ­
p h a g e  inh i b i t o ry a g e n t s  o r  not  i nh i b i t e d e a r l y  enough t o  
a f f e c t  v i r a l  g rowth i n  t h a t  a re a . F ina l l y ,  the po s s i b i l i ty 
e x i s t s  t h a t  mac rophage s d u r i n g  va g in a l  i n fe c t i on a r e  not as  
c r i t i c a l l y  impo r t an t  a s  in  s y s t e m i c  i n f ec t ion and that 
l o c a l  fa c t o r s , such as  pH  of the vag ina l s e c r e t i o n s , may be  
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mo r e  imp o r t ant i n  p r event i n g  v i r a l  r e p l i c a t i on i n  the 
g en i t a l  a r e a . 
Wh i l e  t h e s e  t h r e e  a g e n t s  have b e e n  r ep o r t e d  to  vary 
w i t h  r e s p e c t  to  mechan i sm of ac t ion , they a l l  d e c r e a s ed 
r e s i s t anc e t o  s y s t em i c  HSV - 2 i n f ec t i o n  to  a s im i l a r  d e g r e e .  
Wh i l e  a l l  t h r e e  a g ent s a f f e c t e d  s y s t e m i c  i n f e ct i o n , none o f  
t h e  a gent s a f f e c t e d  va g in a l  i n f e c t i o n . Whe t h e r  o r  not 
func t i o n s  wh i c h  r e qu ir e  ma c ropha g e s  in  an acc e s s o ry ro l e  
wa s not  d e t e rm i ne d , a l though i t  was o b s e r v e d  that none o f  
t h e  a g ent s ma r k e d l y  a f f e c t e d  v i ru s - sp e c i f i c  ant i b o dy t o  
HSV - 2 .  I t  s e ems  e v i dent , howeve r , that mac rophage d y s func -
t i on pro duc e d  b y  va r i o u s  means may cont r i bu t e  s i gn i f i c ant l y  
t o  inc r e a s e d  v i r a l  d i s s e minat i on and u l t i mat e l y  t o  inc r e a s e d  
s u s c e p t i b i l i t y  t o  s y s t em i c  H S V  i n fec t i on . 
The admin i s t ra t i o n  o f  pyran copo l ymer in  v i vo p rophy ­
l ac t i c a l l y  h a s  b e e n  s hown t o  i n c r e a s e  r e s i s t an c e  t o  a numb e r  
o f  v i ru s e s  a s  we l l  a s  t umo r s  in m i c e  (Mc C o r d  e t  a l . ,  1 9 7 6 ; 
Mo rahan e t  a l . ,  1 9 7 4 ; Mo hr e t  a l . ,  1 9 7 5 ) . A l t hough the 
p r e c i s e  mechan i s m of p y r an ' s  act i v i t y  h a s  not  b e e n  comp l e t e l y  
e l uc i d a t e d , t h e r e  a r e  s e v e r a l  l in e s  o f  e v i dence wh ich 
s u g g e s t s  that  t h e  mac ro p ha g e  is  t h e  p r ime t a r g e t  o f  pyran ' s  
ac t i v i t y . Seve r a l  chang e s  in  mac ropha g e  funct i on occur 
fo l l ow i n g  t h e  admin i s t ra t i o n  of pyran inc l u d i n g  inc r e a s e d  
p h a g o c y t o s i s a n d  m i c r o b i c i d a l  a c t i v i t y  (Mo r ahan e t  a l . ,  
1 9 7 4 ) . 
W i t h  r e s p e c t  t o  i t s  ant i v i r a l  a c t i v i t y , pyran a l s o  
app e a r s  t o  me d i a t e  i t s  a c t i v i t y  v i a  the mac r ophage ( B r i en i g  
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e t  a l . ,  1 9 7 8 ) . The ant i v i r a l  act i v i t y  d i s p l ayed when pyran 
wa s admin i s t e r e d  p rophyl ac t i c a l l y  fo l l owed by s y s t em i c  
i n f e c t i on w i t h  s y s t em i c  H S V  i s  no t d u e  t o  humo r a l  T - de p en ­
dent r e s p on s e s  such a s  i nc r e a s e d  neut ra l i z in g  ant i b o dy 
a c t i v i t y . T r e a t ment by pyran c r i t i c a l l y  de l ay e d  the ap ­
p e arance  and p ro duc t i on o f  ant i b o dy a s  comp a r e d  w i t h  un ­
t re a t e d  m i c e , s u g g e s t ing  t h a t  pyran ' s  ant i v i r a l  act i v i t y 
w a s  med i a t e d  t h rough a p henomenon p r e s en t  p r i o r  to  the 
o n s e t  of s p e c i f i c  humo r a l  r e spon s e s  (Mo rahan et  a l . ,  1 9 7 5 ) .  
The inc i d enc e o f  a s p e c i f i c  d e l ayed type hyp e r s en s i t i v i t y 
r e s p o n s e  wa s found t o  be  l e s s  f r e quent in  pyran - t r e a t e d  
m i c e  t han in  un t r e a t e d  m i c e  wh i c h  survived a p r imary cha l ­
l en g e  o f  v i ru s . Furthe rmo r e , Mo rahan and Mc C o r d  ( 1 9 7 5 )  
d emon s t r a t e d  pyran s t i l l  r e t a in e d  i t s  ant i v i r a l  ac t i v i t y  in 
m i c e  dep l e t e d  o f  T - c e l l s . Pyr an - t r e a t e d  m i c e  w e r e  a l s o not  
r e s i s t ant t o  a s e condary s y s t em i c  cha l l en g e  o f  HSV , un l i ke 
unt r e a t e d  m i c e  wh i c h  s ur v i ve d  a p r imary ch a l l en g e  of v i rus , 
p r o v i d in g  fur t he r e v i dence  t ha t  T - c e l l s  we r e  not  invo l ve d  
i n  pyran ' s  ant i v i r a l  a c t i v i t y  ( B r i en i g  e t  a l . ,  1 9 7 8 ) . 
Py ran do e s  no t app e a r  t o  me d i a t e  i t s  ant i v i r a l  e f fect  
t hr o u g h  i n t e r f e ron , n o r  does  i t  d i r e c t l y  inac t i v a t e  the 
v i r u s  (Mc C o r d  e t  a l . ,  1 9 7 6 ) . Pyran - t r e a t e d  p e r i t o ne a l  
c e l l s  a l s o po s s e s s ant i v i r a l  act i v i t y  in  v i t ro a s  e v i denc e d  
by a s i gn i f i c ant r e duc t i o n  in  t h e  l o g l O /ml  y i e l d  o f  HSV - Z 
( Br e in i g  e t  a l . ,  1 9 7 8 ) . Th i s  phenomenon wa s a t t r i but a b l e 
t o  t h e  adhe rent  c e l l p o pu l at i on comp r i s e d  p r imar i l y o f  
e s t e ra s e  p o s i t i ve and l a t e x  p o s i t i ve mac ropha g e s . 
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T r e atment o f  t h i s  popu l a t i on w i t h  s i l i ca  a l mo s t  comp l e t e l y  
a b r o g a t e d  t h e  r e s p o n s e  ( Br i en i g  e t  a l . ,  1 9 7 8 ) . 
Thus , i t  wa s o f  i nt e r e s t  i n  our  s t ud i e s  t o  d e t e rmine 
i f  s yn g e n e i c  p e r i t on e a l  c e l l s  from pyran - t r e a t e d  adu l t  m i c e  
co u l d  p ro t e c t  neonat a l  macrophage - de f i c i en t  m i c e  from a 
s y s t em i c  l e t h a l  HSV i n fe c t i on . Conco rdant w i t h  t h e  find i n g s  
o f  H i r s c h  e t  a l . ( 1 9 7 0 ) , i t  wa s no t e d  that  no rma l p e r i ­
t o n e a l  c e l l s  a f f o r d e d  no  p r o t e c t i on . I n  cont r a s t , p a s s ive 
t ra n s f e r  p e r i t o n e a l  c e l l s  from pyran - t re a t e d  m i c e  when 
p a s s i ve l y  t ra n s f e r r e d  i n t o  n e onat e s  s i gn i f i c ant l y  r e duc e d  
t h e  mo r t a l i ty ra t e . G l yc o g en - t r e a t e d  p e r i t o n e a l  c e l l s  
a f f o r d e d  s o me p r o t e c t i on a l t hough not  t o  t he d e g r e e  wh i c h  
wa s o b s e rved by pyran c e l l s .  Th i s  sug g e s t s  t ha t  g l yc o g en 
mo d u l a t e s  macrophage  a c t i v i t y in  s ome fa s h i on but whe t h e r  
t h e s e  c e l l s  a r e  a c t ivat e d  in  t h e  c l a s s i c s en s e  wa s n o t  
d e t e rm i ne d .  I t  wa s o b v i o u s , howeve r , that  ne i t h e r  pyran 
nor g l yc o g e n  e x e r t e d  a d i r e c t  ant i v i r a l  e f f e c t  by v i r t ue o f  
t h e  fact t h a t  neona t e s  t r e a t e d  w i t h  g l yc o g en o r  pyran we r e  
n o t  p r o t ec t e d . C l e a r l y , pyran modu l a t e d  ma c ropha g e  func ­
t ion by way o f  a c e l l  t ran s fe r r e d  i n t o  t h e  neona t e s . 
F o l l o w i n g  t h e  o b s e rvat i o n s  that  t ran s fe r  o f  mac rophage 
in  v ivo mark e d l y  i nc r e a s e d  r e s i s t ance to  s y s t e m i c  HSV - 2  
i n fe c t i o n , i t  wa s o f  i n t e r e s t  t o  d e t e rmine i f  the ant i v i r a l  
ac t i v i t y  o f  p e r i t o n e a l  e xu d a t e  c e l l s  a ga in s t  H S V  c o u l d  b e  
d e t e c t e d  i n  an in v i t ro s i tuat i on . Thus , a s y s t e m  wa s 
d e s i gn e d  t o  l o o k  a t  the inh i b i t ion of v i ra l r ep l i c a t i o n  by 
p e r i t o n e a l  e xuda t e  c e l l s  from m i c e  i n f e c t e d  w i t h  HSV , 
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r e c o gn i z in g  t h a t  the  p e r i tone a l  exud a t e  rep r e s ent s a popu ­
l a t i on having a comp a r a t ive l y  h i gh p e r c e n t a g e  o f  macropha g e s . 
S in c e  the  p e r i t o n e a l  exudate wa s t o  b e  the s ource  o f  e f fec t o r  
ce l l s ,  t h e  p e r i t o n e a l  c a v i t y  w a s  cho s en a s  t h e  route o f  
i n fe c t i on , a s  t h i s  wa s l i k e l y  t o  p r o v i d e  the  mo s t  d i r e c t  
i nt e ra c t i o n  b e tween v i rus  a n d  e f fe c t o r  c e l l .  A s  a r e s u l t 
o f  t he s e  s t ud i e s , s e ve r a l  ob s e rvat ion s we re made . 
Pe r i t o n e a l  e xuda t e  c e l l s  from i n fe c t e d  m i c e  we r e  
c a p a b l e  o f  s i gn i f i c an t l y  r e duc i n g  v i r a l  r ep l i c a t i on in  
v i t ro . Th i s  e ff e c t  a p p e a r e d  e a r l y  du r in g  the  cour s e  o f  in  
v ivo i n f e c t i on , p r i o r  to t he o n s e t  of s p e c i f i c  humo r a l  and 
c e l l - me d i a t e d r e sp on s e s  (Mo r ahan e t  a l . ,  1 9 7 7 ) . The r e ­
s p o n s e  wa s t ran s i en t , ap p e a r i n g  2 days fo l l owing i n fect i on 
in  v i vo , p e a k ing a t  3 - 4  days and wan ing by day 7 ,  a t ime at 
wh i c h  s p e c i f i c  CM I and humo r a l  r e s p on s e s  be come app a r ent . 
The s e  r e su l t s  a r e  s im i l a r  t o  t ho s e  r ep o r t e d  by Ro dda and 
Wh i t e  ( 1 9 7 6 )  u s i n g  a cyt o t o x i c i t y a s s ay i n  the  Seml i k i  
Fo r e s t  v i r u s  s y s t em ,  but t h e  e ffec t o r  ce l l  in  that  sys t em 
wa s a nonph agocyt i c  NK c e l l  (Ma c F a r l an e t  a l . ,  1 9 7 7 ) . 
The maj o r i t y o f  the  ant i v i r a l  a c t i v i t y  app e a r e d  to  
r e s i d e  in  the  adherent p o pu l a t i on o f  ce l l s ,  a s  e v i denc e d  by 
t he fact t h a t  nonadhe rent c e l l s  a l one provided no  i n h i b i ­
t i on o f  v i ra l  rep l i c a t i on , and remova l o f  the s e  ce l l s  from 
the  t o t a l  popu l a t i o n  d i d  not  change the  d e g r e e  inh i b i t i on 
o f  t h e  r e ma i n in g  a dh e r ent c e l l s .  The s e  adh e r e n t  c e l l s  
c on s i s t e d  p r imar i l y  o f  c e l l s  r e s emb l ing  ma c ropha g e s  ( 6 5 -
8 0 % )  b a s e d  on  mo rpho l o g y , l a t e x  p ar t i c l e  inge s t i o n , and the 
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p r e s en c e  o f  t h e  n o n s p e c i f i c e s t e r a s e  e n z yme . Thu s , i t  i s  
t emp t i n g  to  s u g g e s t  t h a t  t h e  mac rophage  i s  t h e  p r ime e f ­
f e c t o r  c e l l  r e s p on s i b l e  for  t h e  o b s e rv e d  ant i v i r a l  ac t iv ­
i t y . Howeve r ,  a l t hough t h e  t e rm "mac ropha g e "  i s  u s e d  
i n t e rchan g e a b l y  w i t h  adherent p e r i tone a l  exuda t e  c e l l , i t  
i s  r e c o gn i z e d  t h a t  p e r i t o n e a l  c e l l s  r e p r e s ent a very h e t e ro ­
g e n o u s  popu l a t i o n . The po s s ib i l i t y  e x i s t s  that  t h e  ant i ­
v i r a l  ac t i v i t y  r e s i d e s  i n  t he p a r t  o f  the adherent popul a ­
t i on t h a t  do not  r e s emb l e  macropha g e s , such a s  tho s e  r e ­
p o r t e d  by Na than e t  a l . ( 1 9 7 7 ) . They d e s c r i b e d  a c e l l  
r e p r e s en t i n g  a r e l a t ive l y  sma l l  p e rc e n t a g e  o f  the adherent 
c e l l popu l a t ion wh i c h  was e s t e r a s e  po s i t ive , nonphagocy t i c , 
l ac k in g  EAC r e c ep t o r s , and r e s i s t ant to  k i l l i ng w i t h  ant i ­
mac r o p h a g e  s e rum . Th e s e  c e l l s  we re mo r e  p r e va l ent in BC G ­
t re a t e d  m i c e  wh i c h  s u g g e s t s  t ha t  an ac t ivat ing mechan i s m 
may s t imu l a t e  t h e  p roduc t i o n  o f  t he s e  c e l l s ,  wh i ch may o r  
may n o t  b e  ana l o go u s  t o  o u r  s y s t em .  Furthermo re , t he s e  
c e l l s  we r e  cap a b l e  o f  k i l l in g  t umor c e l l s  i n  v i t ro , a 
p henomenon wh i c h  h a s  a l s o b e e n  o b s e rved w i t h  HSV c e l l s  from 
H SV - i n fe c t e d  m i c e  (Mo r s e , p e r sona l commun i cat i o n ) . 
Furt h e r  charac t e r i z a t ion o f  t h e  ant i v i r a l  ac t iv i t y  o f  
a dh e rent p o pu l a t i o n  o f  p e r i t o n e a l  exud a t e  c e l l s  from HSV ­
i n fe c t e d  m i c e  r e ve a l e d s ev e r a l  o t h e r  charac t e r i s t i c s . The 
ant i v i r a l  a c t i v i ty wa s do s e  r e s p on s ive . As the numb e r  o f  
p e r i t on e a l  c e l l s  a d d e d  t o  i n fe c t e d  c u l t u r e s wa s d e c r e a s e d , 
s o  d i d  t h e  d e g r e e  o f  v i ra l  inh i b i t ion . A m i n i mum ra t i o o f  
1 : 2  macropha g e : t ar g e t  c e l l s  was  r e qu i r e d . The act i v i ty wa s 
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non s pe c i f i c  w i t h  r e g a r d  t o  v i rus  s p e c i e s . C e l l s  from HSV ­
i n f e c t e d  m i c e  inh i b i t e d  in  v i t ro a t o t a l l y  un r e l at e d  RNA 
v i r u s , v e s i c u l a r  s t omat i s  v i r u s , a s  we l l  a s  HSV - Z .  Mo r e ­
ove r ,  t h e r e  a p p e a r e d  t o  b e  no o b s e rvab l e  r e q u i r ement fo r 
h i s t o compat i b i l i t y  be tween e f f e c t o r  and t a r g e t  c e l l  s ince 
mo u s e  p e r i t on e a l  c e l l s  i nh i b i t e d  v i r a l  r e p l i c a t i o n  in  
xeno g en e i c  V e ro monk ey k i dney c e l l s  as  we l l  a s  in  syngene i c  
mo u s e  embryo f i br o b l a s t s . Thus , the r e s p o n s e  a l though 
n o n s pe c i f i c  d i d  not  a p p e a r  t o  b e  me d i a t e d  by "c l a s s i c "  
i n t e r fe r o n , d u e  t o  t h e  fact t ha t  t h e r e  wa s n o  s p e c i e s  
s p e c i f i c i ty i nvo l ve d  w i t h  r e g a r d  t o  t ar g e t  and e f fe c t o r  
c e l l .  
The p o int  mu s t  a l s o b e  d i s c u s s e d  conc e r n i n g  the ant i ­
v i r a l  ac t i v i t y  o f  no rma l mac rophage s .  Act i v i t y  was o b s e rved 
i n  some c a s e s  when no rma l PEC  were added t o  cu l t ure s .  
Howeve r ,  t h e  ant i v i r a l  a c t i v i t y  wa s much mo r e  incon s i s t ent 
and neve r ach i ev e d  t h e  amount of inh i b i t i on e xh i b i t e d by 
PEC o b t a i n e d  from HSV - i n fe c t e d  m i c e . I t  i s  po s s i b l e  t ha t  
in  t h e  p r e s en c e  o f  v i r u s - i n f e c t e d  c e l l s  in  v i t ro t h a t  
n o rm a l  macrophag e s  w e r e  a c t i v a t e d  dur in g  t he t h r e e  day 
c u l t u r e  p e r i o d . A l t e rn a t i ve l y , it i s  p o s s i b l e  that  mac r o ­
p ha g e s  a r e , t o  s ome e x t ent , in a con s t an t  s t a t e  o f  "a ct iva ­
t i o n "  and a r e  cap a b l e  o f  n o n s p e c i f i c a l l y  e l i c i t i n g  an 
a n t i v i r a l  e f f e c t . I t  s e ems  r e a s o n ab l e  t o  s t at e , howeve r , 
t h a t  mac ropha g e s  from HSV - Z i n f e c t e d  m i c e  unde r go s ome 
d e g r e e  o f  change  or a l t e ra t ion wh i c h  ma k e s  them much mo r e  
e f fe c t ive  i n  i nh i b i t i n g  v i r a l  r e p l i c a t i o n . Whe t h e r  t h i s  
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change i s  ana l o go u s  t o  " a c t iva t i o n "  a s  w i t h  BCG , pyran o r  
o t h e r  synthe t i c a g e n t s  o r  s t imul a t ion a s  w i t h  g l yco gen was  
n o t  d e t e rm i ne d .  Pr e l iminary e x p e r iment s by Mo r s e  e t  a l . 
( manu s c r ip t  in p r ep a r a t i o n )  have ind i c a t e d  that HSV PEe , 
l i k e  pyran - ac t i v a t e d  c e l l s ,  a r e  c apab l e  o f  k i l l in g  t umo r 
c e l l s  in v i t ro , a c r i t e r i a wh i c h  h a s  b e en a s s o c i a t e d  w i t h  
c l a s s i c a l  mac ropha g e  a c t i va t i o n . 
T h e r e  have b e e n  comp a r a t ive l y  few repo r t s  con c e rn i n g  
t h e  ant i v i r a l  a c t i v i t y  o f  mac rophage s a g a i n s t  HSV - 2  i n f e c t e d  
t a r g e t  c e l l s  ( e x t r in s i c ant i v i r a l  ac t iv i t y ) . Con s i d e r ab l y  
mo r e  d a t a  a r e  a va i l ab l e  r e g a r d ing t h e  int r i n s i c  an t i v i r a l  
ac t i v i t y  o r  t h e  r e s p o n s e  o f  t h e  mac rophage  d i r e c t l y  t o  the 
v i r u s . I t  ha s b e en s hown t h a t  t h e r e  a r e  c on s i d e rab l e  
d i f fe re nc e s  i n  t he r e l a t ive  s u s c ep t i b i l i t i e s  among d i f -
f e r e n t  inb r e d  s t ra in s  o f  m i c e  t o  i n t r ap e r i t o n e a l  HSV i n f e c -
t ion ( Lop e z , 1 9 7 6 ) . I t  wa s thus o f  i nt e r e s t  to  d e t e rmine 
i f  t h e  ab i l i t y  of t h e  ma c r op ha g e  t o  inh i b i t  o r  supp o r t  
v i ra l  r ep l i c at ion in v i t ro c o u l d  b e  c o r r e l a t e d  w i t h  re l at ive  
r e s i s t an c e  in v i vo . The recent  repo r t  o f  Lop e z  and Dud a s  
( 1 9 7 9 ) us i n g  H SV , and Se l g rade a n d  O s bo rne ( 1 9 7 4 )  us ing 
mur ine  cytome g a l o v i ru s  sug g e s t  that s uch a c o r r e l at ion do e s  
not  e x i s t  i n  t h e  g e ne t i c  r e s i s t an c e  s hown by adu l t  m i c e . 
Th i s  app e a r s  in c ont r a s t  to  J o hn s o n ' s  f i n d i n g s  wh i c h  showed 
that t h e  h i gh s u s c e p t i b i l i t y  of newbo rn m i c e  to  HSV - 2 
i n f e c t ion was  c o r r e l a t e d  wi th the ab i l i ty o f  mac roph a g e s  to  
supp o r t  v i r a l  r e p l i c a t ion . Howeve r ,  i t  s ho u l d  be r e c o gn i z e d  
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t hat John s o n ' s  s y s t em de a l t  w i t h  a g e - r e l a t e d  r e s i s t ance and 
L o p e z ' s  s y s t em i nvo l ve d  the  r e s i s t ance of adul t m i c e  as 
g en e t i c a l l y  d e t e rmin e d . D i f ferent mechan i s ms are l ik e l y  to 
be o p e r a t ive . 
No  r ep o r t s t o  d a t e  have b e en ava i l ab l e  conc e r n i n g  the  
e xt r i n s i c  ant i v i r a l  a c t i v i ty of  adherent p e r i t o n e a l  e xud a t e  
c e l l s  f r o m  m i c e  i n fe c t e d w i t h  HSV - 2 .  Lodme l l  e t  a l . ( 1 9 7 3 )  
u s i n g  HSV - l  i n fe c t e d rabb i t  k i dney mono l ay e r s  demons t ra t e d  
t ha t  p e r i t o n e a l  e xud a t e s  f r o m  rabb i t s  inj e c t e d  w i th c a s i n a t e  
w e r e  cap a b l e  o f  inh i b i t ing  v i r a l  p l aque fo rmat i on i n  
v i t r o . Much h i gh e r  r a t i o s  o f  mac r o p h a g e s  t o  t a r g e t  ce l l s  
( 5 0 : 1 ) t han in the  p r e s en t  s tudy were ne c e s s ary to  p roduce 
the  e f f e c t . I t  was  s ug g e s t e d  that  th i s  act i v i ty wa s a 
r e s u l t o f  the  a b i l i t y  o f  the  l euko c y t e s  t o  inh i b i t  fo rma ­
t i on o f  in t r ac e l l u l a r  b r i d g e s  by dama g in g  i n fe c t e d  c e l l s  
and s u r r o und i n g  adj acent  c e l l s . An t i b o dy wa s e f fect ive in  
p r o h i b i t i n g  e x t r a c e l l u l a r  s p r e a d , but wa s unab l e  to  inh i b i t  
c e l l  t o  c e l l  s p r e a d  o f  i n f ec t i o n . 
Sub s e quent t o  t h i s  wo r k , L o dme l l  and c o - wo rk e r s  ( 1 9 7 4 )  
us i n g  a s im i l ar s y s t em r e p o r t e d  that  c e l l s  from rabb i t s  
immun i z e d  i n  v i v o  w i t h Myc o b a c t e r ium t u r b e rc u l o s i s  were 
c ap a b l e  of  inh i b i t ing  v i r a l  growth in  HSV - i n f e c t e d  rabb i t  
k i dney mono l aye i s i n  the p r e s ence o f  P P D . S im i l a r l y , 
l eukocyt e s  from HSV - 2 s en s i t i z ed  anima l s  we re capab l e  o f  
i nh i b i t i n g  v i r a l  r e p l i c a t i on i n  v i t ro . I t  wa s s ug g e s t e d  
t h a t  int e r f e ron p roduc e d  b y  s e n s i t i z e d  l euko c y t e s  m i ght  b e  
t he med i a t o r  o f  t h i s  ant i v i r a l  act i v i t y . On l y  at h i g h 
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e f f e c t o r : t a r g e t  c e l l  r a t i o s  d i d  uns ens i t i z e d  l euko c y t e s  
e x e r t  a n  ant i v i r a l  e ff e c t  t hrough a g e n e ra l i z e d  nonsp e c i f i c 
e ff e c t , and l i t t l e  o r  no i n t e r f e r on wa s d e t e c t ab l e  in  the s e  
c u l t u r e s . 
Mo rahan e t  a l . ( 1 9 7 7 )  r e p o r t e d  e xt r in s i c  mac rophag e ­
med i a t e d  ant i v i r a l  a c t i v i t y  o f  p e r i t o n e a l  e xud a t e  c e l l s  
from m i c e  t r e a t e d  w i t h  pyran , �.  pa rvum o r  i n f e c t e d  w i t h  
vacc i n i a  v i r u s . S i m i l ar t o  t h e  f i n d i n g s  o f  L o dme l l  e t  a l . 
( 1 9 7 3 ,  1 9 7 4 ) , i t  wa s s u g g e s t e d  t h a t  int e r fe ron m i ght b e  
i nvo l v e d  i n  t h e  ant i v i r a l  a c t i v i t y  o f  vacc i n i a  P E e . I n  
s up p o r t  o f  t h i s , K i r c hn e r  e t  a l . ( 1 9 7 7 )  r e p o r t e d  t h a t  � .  
pa rvum a c t i va t e d  s p l e e n  and p e r i t on e a l  c e l l s  we r e  capab l e  
o f  p r o duc i n g  an ant i v i r a l  fac t o r  wh i c h  w a s  t r yp s in s e n s i ­
t iv e , s p e c i e s  sp e c i f i c  and v i ru s  n o n s p e c i f i c . Thus , i t  was 
d e t e rm i n e d  to b e  i n t e r f e ron . 
Seve r a l  ana l o g i e s  may b e  d rawn to  t h e  d a t a  p r e s en t e d  
f r o m  t h i s  wo r k  a n d  t h e  wo r k  o f  o t he r s . The mo s t  o b v i o u s  
s im i l a r i ty i s  t h e  f a c t  t h a t  i n  r e p o r t s , the ant i v i r a l  
a c t i v i t y  o f  t h e  mac ropha g e s  wa s nonspec i f i c  w i t h  r e g a r d  t o  
v i r u s  s p e c i f i c i t y . S e c o n d l y ,  t h e  a c t i v i t y  d i sp l a y e d  by 
t he s e  c e l l s  was c ap a b l e  o f  r e s t r i c t i n g  int e rc e l l u l a r  s p r e a d  
o f  v i rus a n d  p e rh a p s  e x t r ac e l l u l a r  s p r e a d . A l t hough t h i s  
imp l i e s  t h a t  t h e  mechan i s ms o f  ant i v i r a l  act i v i t y  o f  t h e  
e ff e c t o r  c e l l s  i nvo l v e d  i n  t h e  va r i ous  s y s t ems may in  fact 
be  s im i l a r , t h e  data on  i n t e r fe r on invol vement i n d i c a t e  
t h a t  d i f f e r i n g  mechan i s ms mu s t  b e  o p e r a t i ve . 
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A l t hough t h e  s c o p e  o f  t h i s  r e s e a rch d i d  not  encomp a s s  
t h e  mechan i sm ( s )  o f  adherent p e r i t one a l  c e l l  (ma c ropha g e )  
ant i v i r a l  ac t iv i ty , i t  i s  t emp t i n g  to  en t e r t a i n  s eve r a l  
hyp o t h e s e s . On e a s p e c t  wou l d  b e  t o  d e t e rmine how t h e  
mac r o p h a g e  int e r a c t s w i t h  t h e  v i rus . Two l i k e l y  s i t ua t i o n s  
e x i s t . The macrophage  may b e  d i r e c t l y  int e ra c t i n g  wi th 
v i rus  and , fo l l ow i n g  phagocyt o s i s , r e s u l t s  in  d e s t r uc t i o n  
o f  t h e  i n fe c t i o u s  v i r io n . Th i s  wou l d , thus , b e  o c c u r r ing 
a t  t h e  e x t r ac e l l u l a r  l eve l , and wou l d  not  accoun t  f o r  
i nh i b i t i o n  o f  c o n t i guous s p r e a d . Al t e rnat i ve l y , i n s t e a d  o f  
a d i r e c t  mac r op h a g e - v i ru s  i n t e r a c t i on , t h e  e f f e c t o r  c e l l  
may e x e r t  i t s  ac t i v i ty t hrough a mac ropha g e - v i rus  i n fe c t e d  
c e l l  i n t e r ac t ion . Th i s  c ou l d  o c cur through a r e c o gn i t i o n  
o f  v i r a l  an t i g e n s  on  t h e  s u r fa c e  o f  i n f e c t e d  c e l l s , fo l ­
l owed by d e s t ruc t i on o f  t h e s e  c e l l s  r e s ul t ing  in  an abor ­
t iv e  v i r a l  r e p l i c a t i o n  cyc l e . Th i s  theo ry c ou l d  accoun t  
f o r  inh i b i t i o n  o f  cont i guous s p r e a d  o f  v i rus . Ot h e r  me cha ­
n i sms  o p e r a t i ve on t h e  t a r g e t  c e l l  that  r e n d e r  i t  nonp e r ­
m i s s i ve f o r  v i r a l  g rowt h  a r e , o f  cou r s e , a l s o  p o s s i b l e . 
A s e cond con s i de r a t i o n  w i th r e g a r d  t o  macropha g e ­
me d i a t e d ant i v i r a l  i nvo l v e s  t h e  i n t e r a ct i o n  o f  the mac ro ­
p h a g e  and e i t h e r  t h e  v i rus  o r  v i ru s - i n f e c t e d  t a r g e t  c e l l . 
P r e l i m i n a ry o b s eiva t i o n s  s u g g e s t  t h a t  d i r e c t  phy s i c a l  
c o n t a c t  be tween t h e  macrophage and v i ru s  o r  infec t e d  c e l l  
may n o t  b e  r e q u i r e d  (Mo r s e , p e r s on a l  commun i c a t i on ) . Th i s  
wou l d  s u g g e s t  t h a t  t h e  macrophage m i ght me d i a t e  i t s  ac t i v i t y  
83 
t h r ough e l abo r a t i o n  o f  s ome type o f  fac t o r . Th i s  fact o r , 
a l t ho u gh we d i d  not  a t t e mp t t o  c h a r ac t e r i z e  i t , app e a r s  n o t  
t o  b e  a " c onvent i o n a l " t yp e  o f  i n t e r f e r on , s in c e  int e r f e r o n  
i s  c l a s s i c a l l y  t hought t o  b e  s p e c i e s - s p ec i f i c . Th i s  was  
not t h e  c a s e  in  our  s y s tem . An t i b o dy a l s o  do e s  no t app e a r  
t o  be  o p e r a t ive  in  t h i s  s y s t e m  s in c e  t h e r e  w a s  no app a r e n t  
s p e c i f i c i t y  t owa r d  t h e  i n i t i a l  i n f ec t i n g  v i ru s . A mo r e  
d e t a i l e d  anal y s i s  o f  t h e  mo l e cul a r  even t s  wh i c h  o c cur 
dur i n g  macropha g e - v i ru s  i n t e r ac t i on s hou l d  p r o v i d e  a mo r e  
comp r ehen s i ve unde r s t and i n g  o f  t h e  mechan i s ms o f  mac r o ­
p h a g e - m e d i a t e d  ant i v i r a l  a c t i v i t y . 
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